FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Fenaux

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Physiology

Mutation

Co-author Network

Publications

TOP 3
Cecile Bally; Caroline Dartigeas; Stéphane de Botton; Benoit de Renzis; Francois Dreyfus; Jehane Fadlallah; Pierre Fenaux; Raphael Itzykson; Bruno Quesnel; Sylvain Thépot; Pascal Turlure; Norbert Vey; Lionel Adès
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Lionel Adès; Francois Dreyfus; Pierre Fenaux; Raphael Itzykson; Alan F List; Jaroslaw P Maciejewski; Mikkael A Sekeres; Melissa L Teichman; Ramon V Tiu; Alice Wolfromm; Rami S Komrokji
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.
C Kelaidi; C Lambert; Laurence Legros; F Pillard; C Rose; Rosa Sapena; B Slama; Aspasia Stamatoullas; A Testu; L Adès; S Ame; M C Béné; Odile Beyne-Rauzy; F Boyer; T Braun; J C Charniot; M P Chaury; Stéphane Cheze; Bachra Choufi; P Cougoul; G Damaj; B De Renzis; François Dreyfus; Agnès Guerci; Emmanuel Gyan; Pierre Fenaux
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Fenaux (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cecile Bally; Caroline Dartigeas; Stéphane de Botton; Benoit de Renzis; Francois Dreyfus; Jehane Fadlallah; Pierre Fenaux; Raphael Itzykson; Bruno Quesnel; Sylvain Thépot; Pascal Turlure; Norbert Vey; Lionel Adès
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Leukemia research 2013;37(6):637-40.
2013: Lionel Adès; Francois Dreyfus; Pierre Fenaux; Raphael Itzykson; Alan F List; Jaroslaw P Maciejewski; Mikkael A Sekeres; Melissa L Teichman; Ramon V Tiu; Alice Wolfromm; Rami S Komrokji
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.
Leukemia research 2013;37(6):609-13.
2013: C Kelaidi; C Lambert; Laurence Legros; F Pillard; C Rose; Rosa Sapena; B Slama; Aspasia Stamatoullas; A Testu; L Adès; S Ame; M C Béné; Odile Beyne-Rauzy; F Boyer; T Braun; J C Charniot; M P Chaury; Stéphane Cheze; Bachra Choufi; P Cougoul; G Damaj; B De Renzis; François Dreyfus; Agnès Guerci; Emmanuel Gyan; Pierre Fenaux
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Annals of hematology 2013;92(5):621-31.
2013: Sophie Park; Marie Robin; Gérard Socié; Reza Tabrizi; Norbert Vey; Ibrahim Yakoub-Agha; Yves Beguin; Marc Bernard; Jean-Henri Bourhis; Thierry de Revel; Eric DECONINCK; Jacques Delaunay; Nathalie Dhedin; François Dreyfus; Pierre Fenaux; Anne Huynh; Myriam Labopin; Simona Lapusan; Bruno Lioure; Mauricette Michallet; Mohamad Mohty
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
European journal of haematology 2013;90(5):355-64.
2013: Andrea Kuendgen; M Lauseker; A F List; Aristoteles Giagounidis; A Glasmacher; J Hasford; J Backstrom; N A Brandenburg; Pierre Fenaux; Ulrich Germing
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis.
Leukemia 2013;27(5):1072-9.
2013: Raphaël Itzykson; Olivier Kosmider; Guillaume Meurice; Margot Morabito; Cédric Oréar; Uwe Platzbecker; Claude Preudhomme; Philippe Rameau; Aline Renneville; Lionel Adès; Olivier A Bernard; Céline Berthon; François Delhommeau; Nathalie M Droin; Pierre Fenaux; Michaëla Fontenay; Olivier Gagey; William Vainchenker; Eric Solary
Clonal architecture of chronic myelomonocytic leukemias.
Blood 2013;121(12):2186-98.
2013: Dennis A Revicki; Ren Yu; Nancy A Brandenburg; Robert Knight; Petra Muus; Pierre Fenaux
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial.
Leukemia research 2013;37(3):259-65.
2013: Carole le Pogam; Christophe Leboeuf; Pascal Merlet; Maria-Elena Noguera; Rose Ann Padua; Marika Pla; Laure Sarda-Mantel; Niclas Setterblad; Annie Soulié; Lionel Adès; Nicole Balitrand; Stephanie Beurlet; Bruno Cassinat; Helene Cavé; Christine Chomienne; Pierre Fenaux; Michaëla Fontenay; Florence Hervatin; Anne Janin; Olivier Kosmider; Patricia Krief; Nader Omidvar
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes.
Leukemia research 2013;37(3):312-9.
2013: Caroline Besson; Laure Cartron; Hicham Elmaaroufi; Pierre Fenaux; Patrick Festy; Nicolas Guirimand; Sarah Jenny; Sandrine Rannou; Frédéric Tresvaux du Fraval; Alain Leplège
Disclosure of myelodysplastic syndrome diagnosis: improving patients' understanding and experience.
European journal of haematology 2013;90(2):151-6.
2013: Thomas Prébet; Sylvain Thepot; François Dreyfus; Pierre Fenaux; Steven D Gore; Norbert Vey
Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure.
Haematologica 2013;98(2):e18-9.
2013: Claude Gardin; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Aline Renneville; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Dominique Bordessoule; Sylvie Castaigne; Karine Celli-Lebras; Sylvie Chevret; Stéphane de Botton; Thierry de Revel; Pierre Fenaux; Nathalie Gachard; Hervé Dombret
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(3):321-7.
2013: Charlotte Dupont; Florence Eustache; Pierre Fenaux; Cécile Bally; Brigitte Benzacken; Nathalie Sermondade; Rachel Lévy
Spontaneous conception after autologous hematopoietic stem cell transplantation: a case report.
Asian journal of andrology 2013;15(1):155-6.
2012: Mathilde Lamarque; Laurence Legros; Bruno Quesnel; Odile Beyne Rauzy; Sophie Raynaud; Christian Recher; Aspasia Stamatoullas; Sylvain Thepot; Pascal Turlure; Norbert Vey; Sorin Visanica; Caroline Dartigeas; Jacques Delaunay; Francois Dreyfus; Pierre Fenaux; Raphael Itzykson; Lionel Adès
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience.
Blood 2012;120(25):5084-5.
2012: Amel Sebaa; Aspasia Stamatoullas; Lionel Ades; Fanny Baran-Marzack; Sophie Dobbelstein; Pierre Fenaux; Soraya Moulessehoul; Marie-Joelle Mozziconacci; Dominique Penther; Thomas Prebet; Christian Récher; Virginie Eclache
Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Genes, chromosomes & cancer 2012;51(12):1086-92.
2012: Elodie Lainey; Carole Leroy; Marie Scoazec; Marie Sébert; Sylvain Thépot; Cyrielle Bouteloup; Stéphane de Botton; Pierre Fenaux; Lorenzo Galluzzi; Guido Kroemer
Erlotinib antagonizes ABC transporters in acute myeloid leukemia.
Cell cycle (Georgetown, Tex.) 2012;11(21):4079-92.
2012: S Patel; Fabien Zassadowski; Y Zhang; D Bonnet; Bruno Cassinat; J M Cayuela; Christine Chomienne; W Cuccuini; Pierre Fenaux; N Ferré; F Louache
Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ⁻/⁻ mice.
Leukemia 2012;26(11):2432-5.
2012: Lionel Adès; Raphael Itzykson; Pierre Fenaux
Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidine.
Seminars in hematology 2012;49(4):323-9.
2012: Andréa Toma; François Dreyfus; Pierre Fenaux; Catherine Cordonnier
Infections in myelodysplastic syndromes.
Haematologica 2012;97(10):1459-70.
2012: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Catherine Cordonnier; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Gérard Socié; Christine Terré; Hervé Dombret
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.
Leukemia research 2012;36(9):1112-8.
2012: Uwe Platzbecker; Kerstin Schaefer-Eckart; Johannes Schetelig; Bart L Scott; Rudolf Trenschel; Lionel Adès; Dietrich Beelen; Martin Bornhäuser; H Joachim Deeg; Gerhard Ehninger; Pierre Fenaux; Jürgen Finke; Ulrich Germing; Raphael Itzykson; Guido Kobbe
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1415-21.
2012: Norbert Gattermann; Agnes Guerci-Bresler; Dany Habr; Andrea Marcellari; Bernard Roubert; Mathias Schmid; Michael Stadler; Kerry Taylor; Dominique Vassilieff; Matteo Della Porta; Pierre Fenaux; Carlo Finelli; Christian Rose
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes.
Haematologica 2012;97(9):1364-71.
2012: Shanti Natarajan-Amé; Sophie Park; C Ravoet; Aline Schmidt; Aspasia Stamatoullas; Norbert Vey; Lionel Ades; Elisabeth Berger; Dominique Bordessoule; Thorsten Braun; Jean-Yves Cahn; Aude Charbonnier; Marie-Pierre Chaury; Stephane Cheze; Francois Dreyfus; Gabriel Etienne; Pierre Fenaux; Agnès Guerci-Bresler; Laurence Legros
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
British journal of haematology 2012;158(2):232-7.
2012: Raphael Itzykson; Bruno Quesnel; Christian Recher; Sylvain Thépot; Eric Wattel; Lionel Adès; Francois Dreyfus; Claude Gardin; Pierre Fenaux
Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohort.
Blood 2012;119(25):6172-3.
2012: Thomas Prébet; Bruno Quesnel; Sylvain Thépot; Odile Beyne Rauzy; François Dreyfus; Benjamin Esterni; Pierre Fenaux; Claude Gardin; Steven D Gore; Norbert Vey
Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.
British journal of haematology 2012;157(6):764-6.
2012: Aline Renneville; T de Revel; Christine Terre; Xavier Thomas; Oumedaly Reman; C Berthon; Nicolas Boissel; Dominique Bordessoule; S de Botton; Sylvie Castaigne; Jean-Michel Cayuela; Nathalie Contentin; Hervé Dombret; Pierre Fenaux; Claude Gardin; Sandrine Hayette; N Helevaut; O Nibourel; Cécile Pautas; Claude Preudhomme
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Leukemia 2012;26(6):1247-54.
2012: Giovanna Cannas; Sylvie Castaigne; Hervé Dombret; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Mauricette Michallet; Cécile Pautas; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Stéphane de Botton; Thierry de Revel; Nicolas Boissel; Xavier Thomas
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.
Leukemia & lymphoma 2012;53(6):1068-76.
2012: Cecile Bally; Andre Baruchel; Yves Bertrand; Bruno Cassinat; Christine Chomienne; Herve Dombret; Jehane Fadlallah; Pierre Fenaux; Agnes Guerci; Nadia Idres; Thierry Leblanc; Guy Leverger; Emmanuel Raffoux; Christian Recher; Alain Robert; Miguel Sanz; Xavier Thomas; Norbert Vey; Lionel Adès
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1641-6.
2012: Raphael Itzykson; Pierre Fenaux
Predicting the outcome of patients with higher-risk myelodysplastic syndrome treated with hypomethylating agents.
Leukemia & lymphoma 2012;53(5):760-2.
2012: Sylvie Castaigne; Sylvie Chevret; Nathalie Contentin; Noémie de Gunzburg; Thierry de Revel; Hervé Dombret; Pierre Fenaux; Lauris Gastaud; Estelle Henry; Ollivier Legrand; Jean-Pierre Marolleau; Cécile Pautas; Claude Preudhomme; Emmanuel Raffoux; Oumedaly Reman; Philippe Rousselot; Christine Terré; Xavier Thomas; Pascal Turlure; Ahmad Aljijakli; Jean-Noel Bastie; Dominique Bordessoule
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Lancet 2012;379(9825):1508-16.
2012: R Itzykson; Laurence Legros; Jean-Valère Malfuson; C Salanoubat; Anne-Laure Taksin; S Thépot; Pascal Turlure; Norbert Vey; Lionel Ades; S Ame; C Berthon; Odile Beyne-Rauzy; Simone Boehrer; Y Chelgoum; François Dreyfus; Pierre Fenaux; Claude Gardin; F Isnard
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Leukemia research 2012;36(4):397-400.
2012: Camille Cohen; Pierre Fenaux; Romain Gherardi; Arsene Mekinian; Nathalie Saidenberg-Kermanac'h; Jerôme Stirnemann; Olivier Fain
Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
Annals of the rheumatic diseases 2012;71(4):628-9.
2012: Raphael Itzykson; Pierre Fenaux
Optimizing hypomethylating agents in myelodysplastic syndromes.
Current opinion in hematology 2012;19(2):65-70.
2012: David Sibon; Bohrane Slama; Norbert Vey; Eric Wattel; Anne Banos; Fiorenza Baracco; Caroline Besson; Michel Blanc; Giovanna Cannas; Selim Corm; Pierre Fenaux; Hervé Perrier; Thomas Prebet
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents.
British journal of haematology 2012;156(5):619-25.
2012: Lionel Adès; Anne Banos; Michel Blanc; Didier Bouscary; Agnès Guerci Bresler; Marie-Paule Cabrol; Sylvie Chevret; Jacques Delaunay; Alain Delmer; François Dreyfus; Virginie Eclache; Charikleia Kelaidi; Thierry Lamy; Fabien Le Bras; Marie Sebert; Pascal Turlure; Norbert Vey; Sorin Visanica; Eric Wattel; Pierre Fenaux
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies.
Haematologica 2012;97(2):213-8.
2012: Risha Gidwani; Zeba M Khan; C L Beach; Pierre Fenaux; Chris L Pashos
A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes.
Journal of medical economics 2012;15(1):145-54.
2011: Segolene Billot; Antoine F Carpentier; Bruno Cassinat; Pierre Fenaux; Caroline Jardin; Eirini G Kouroupi; Thierry Laperche; Johan Le Guilloux; Jean-Jacques Kiladjian
Neurological disorders in essential thrombocythemia.
Haematologica 2011;96(12):1866-9.
2011: Elodie Lainey; Marie Sébert; Maximilien Tailler; Sylvain Thépot; Cyrielle Bouteloup; Stéphane de Botton; Pierre Fenaux; Claude Gardin; Guido Kroemer; Lionel Adès; André Baruchel; Simone Boehrer
Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action.
Biochemical pharmacology 2011;82(10):1457-66.
2011: Sophie Park; C Rose; Rosa Sapena; B Slama; Aspasia Stamatoullas; Gérard Tertian; D Vassilieff; Norbert Vey; Odile Beyne-Rauzy; Dominique Bordessoule; Stéphane Cheze; Pierre Fenaux; Agnès Guerci; C Kelaidi; Shanti Natarajan-Amé; François Dreyfus
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.
Leukemia research 2011;35(11):1530-3.
2011: Fabien Le Bras; Delphine Rea; Aline Schmidt; Marie Sebert; Pascal Turlure; Norbert Vey; Sorin Visanica; Anne Banos; Odile Beyne-Rauzy; Michel Blanc; Stéphane de Botton; Jacques Delaunay; Alain Delmer; François Dreyfus; Virginie Eclache; Pierre Fenaux; Agnès Guerci; Charikleia Kelaidi; Thierry Lamy; Lionel Adès
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.
Leukemia research 2011;35(11):1444-8.
2011: Thorsten Braun; Benoit de Renzis; François Dreyfus; Nathalie M Droin; Pierre Fenaux; Michaëla Fontenay; Claude Gardin; Raphael Itzykson; Bertrand Joly; Ingrid Lafon; Kamel Laribi; Guillaume Meurice; Cédric Oréar; Claude Preudhomme; Christian Recher; Aline Renneville; Bruno Royer; Laurence Sanhes; Eric Solary; Andrea Toma; Anne Vekhoff; Norbert Vey; Lionel Ades; Krimo Bouabdallah
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.
Blood 2011;118(14):3824-31.
2011: Pierre Fenaux; John Francis; Tommy Fu; Arnold Ganser; Aristoteles Giagounidis; Agnes Guerci-Bresler; Eva Hellström-Lindberg; Robert Knight; Michael Lübbert; Moshe Mittelman; Ghulam Mufti; Petra Muus; Lars Nilsson; Uwe Platzbecker; Bruno Quesnel; Guillermo Sanz; Brigitte Schlegelberger; Dominik Selleslag; Peter Te Boekhorst; Carlo Aul; Odile Beyne-Rauzy; David Bowen; Mario Cazzola; Consuelo Del Cañizo
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Blood 2011;118(14):3765-76.
2011: Simone Boehrer; Cyrielle Bouteloup; Stéphane de Botton; Pierre Fenaux; Lorenzo Galluzzi; Claude Gardin; Francis Harper; Elodie Lainey; Gérard Pierron; Marie Sébert; Maximilien Tailler; Sylvain Thépot; Lionel Adès; Guido Kroemer
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.
Cell cycle (Georgetown, Tex.) 2011;10(18):3168-75.
2011: Sondes Hadiji Mseddi; Ines Jedidi; Faten Kallel; Olfa Kassar; Halima Sennana; Moez Elloumi; Pierre Fenaux
Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.
Leukemia research 2011;35(9):e175-6.
2011: Thomas Prébet; Bruno Quesnel; Odile Beyne Rauzy; Christian Recher; Sylvain Thepot; Lionel Adès; C L Beach; François Dreyfus; Benjamin Esterni; Pierre Fenaux; Claude Gardin; Steven D Gore; Raphael Itzykson; Norbert Vey
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3322-7.
2011: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Yosr Hicheri; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Christine Terré; Hervé Dombret
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.
Blood 2011;118(7):1754-62.
2011: Raphael Itzykson; Pierre Fenaux
[Hypomethylating agents for the treatment of myelodysplastic syndromes].
Bulletin du cancer 2011;98(8):927-34.
2011: R Itzykson; O Kosmider; Véronique Mansat-De Mas; Claude Preudhomme; B Quesnel; S Raynaud; Norbert Vey; L Adès; Odile Beyne-Rauzy; T Cluzeau; François Dreyfus; Pierre Fenaux; Michaëla Fontenay; Véronique Gelsi-Boyer
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
Leukemia 2011;25(7):1147-52.
2011: R Itzykson; B Quesnel; Christian Recher; S Thépot; Pascal Turlure; Norbert Vey; L Adès; Odile Beyne-Rauzy; S Boehrer; François Dreyfus; Virginie Eclache; Pierre Fenaux; Claude Gardin
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine.
Leukemia 2011;25(7):1207-9.
2011: Chantal Lagresle-Peyrou; Elizabeth MacIntyre; Bénédicte Neven; Capucine Picard; Isabelle Radford-Weiss; Emmanuelle Six; Vahid Asnafi; Blandine Beaupain; Yves Bertrand; Chantal Brouzes; Christine Chomienne; Corinne Demerens-de Chappedelaine; jean donadieu; Virginie Eclache; Pierre Fenaux; Alain Fischer; Nada Jabado; Marina Cavazzana-Calvo
Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.
The Journal of allergy and clinical immunology 2011;128(1):230-232.e2.
2011: Thorsten Braun; Bruno Cassinat; Sylvie Castaigne; Valérie Coiteux; Stéphane de Botton; François Dreyfus; Virginie Eclache; Pierre Fenaux; Michaela Fontenay; Khaled Guenda; Agnès Guerci; Anne Lazareth; Geneviève Leroux; Sophie Park; Rosa Sapena; Aspasia Stamatoullas; Anne-Laure Taksin; Christine Terré; Norbert Vey; Odile Beyne-Rauzy; Dominique Bordessoule; Lionel Adès
Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
Leukemia research 2011;35(7):863-7.
2011: Lewis R Silverman; Pierre Fenaux; Norbert Gattermann; Steven D Gore; Eva Hellström-Lindberg; Alan F List; Ghulam J Mufti; Valeria Santini; Guillermo Sanz; John F Seymour
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.
Cancer 2011;117(12):2697-702.
2011: Romain Aucagne; Nathalie M Droin; Jérôme Paggetti; Brice Lagrange; Anne Largeot; Arlette Hammann; Amandine Bataille; Laurent Martin; Kai-Ping Yan; Pierre Fenaux; Régine Losson; Eric Solary; Jean-Noël Bastie; Laurent Delva
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
The Journal of clinical investigation 2011;121(6):2361-70.
2011: Raphael Itzykson; Cécile Pautas; Emmanuel Raffoux; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Sylvie Castaigne; Hervé Dombret; Pierre Fenaux; Claude Gardin
Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria.
Haematologica 2011;96(6):837-44.
2011: Aristoteles Giagounidis; Susanna Leto di Priolo; Susanne Ille; Pierre Fenaux
A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS.
Annals of hematology 2011;90(6):667-73.
2011: Virginie Prendki; Pierre Fenaux; Rémy Durand; Marc Thellier; Olivier Bouchaud
Strongyloidiasis in man 75 years after initial exposure.
Emerging infectious diseases 2011;17(5):931-2.
2011: Bruno Cassinat; Fabien Zassadowski; Christèle Ferry; L Llopis; N Bruck; E Lainey; V Duong; A Cras; Gilles Despouy; O Chourbagi; G Beinse; Pierre Fenaux; Cécile Rochette-Egly; Christine Chomienne
New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1/2 in histone modification and retinoic acid receptor α recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation.
Molecular and cellular biology 2011;31(7):1409-18.
2011: Mikkael A Sekeres; Hagop Kantarjian; Pierre Fenaux; Pamela Becker; Adam Boruchov; Agnes Guerci-Bresler; Kuolung Hu; Janet Franklin; Yow-Ming C Wang; Dietmar Berger
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
Cancer 2011;117(5):992-1000.
2011: Guillermo Garcia-Manero; Pierre Fenaux
Hypomethylating agents and other novel strategies in myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(5):516-23.
2011: Gudrun Göhring; Aristoteles Giagounidis; Guntram Büsche; Winfried Hofmann; Hans H Kreipe; Pierre Fenaux; Eva Hellström-Lindberg; Brigitte Schlegelberger
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.
Haematologica 2011;96(2):319-22.
2011: Raphael Itzykson; Sylvain Thépot; Bruno Quesnel; François Dreyfus; Odile Beyne-Rauzy; Pascal Turlure; Norbert Vey; Christian Recher; Caroline Dartigeas; Laurence Legros; Jacques Delaunay; Célia Salanoubat; Sorin Visanica; Aspasia Stamatoullas; Francoise Isnard; Anne Marfaing-Koka; Stephane de Botton; Youcef Chelghoum; Anne-Laure Taksin; Isabelle Plantier; Shanti Ame; Simone Boehrer; Claude Gardin; C L Beach; Lionel Adès; Pierre Fenaux
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Blood 2011;117(2):403-11.
2011: Ramzi Jeddi; Kacem Karima; Samia Menif; Zarrouk Mohamed; Ali Saad; Lamia Aissaoui; Zaher Belhadjali; Yosr Ben Abdennebi; Hela Ben Abid; Ramzi Ben Amor; Raihane Ben Lakhal; Hend Ben Neji; Naouel Ben Salah; Pierre Fenaux; Hèla Ghédira; Emna Gouider; Raouf Hafsia; Balkis Meddeb
Treatment of Acute Promyelocytic Leukemia with AIDA Based Regimen. Update of a Tunisian Single Center Study.
Mediterranean journal of hematology and infectious diseases 2011;3(1):e2011033.
2010: Fanny Baran-Marszak; Hajer Magdoud; Christophe Desterke; Anabell Alvarado; Claudine Roger; Stéphanie Harel; Elizabeth Mazoyer; Bruno Cassinat; Sylvie Chevret; Carole Tonetti; Stéphane Giraudier; Pierre Fenaux; Florence Cymbalista; Nadine Varin-Blank; Marie-Caroline Le Bousse-Kerdilès; Jean-Jacques Kiladjian; Laura Velazquez
Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
Blood 2010;116(26):5961-71.
2010: Lionel Adès; Pierre Fenaux
[The 5q- syndrome].
La Revue du praticien 2010;60(10):1420-2.
2010: John F Seymour; Pierre Fenaux; Lewis R Silverman; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Alan F List; Steven D Gore; Jay Backstrom; David McKenzie; C L Beach
Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.
Critical reviews in oncology/hematology 2010;76(3):218-27.
2010: Sylvain Thepot; Raphael Itzykson; Valerie Seegers; Emmanuel Raffoux; Bruno Quesnel; Yasmine Chait; Lucile Sorin; Francois Dreyfus; Thomas Cluzeau; Jacques Delaunay; Laurence Sanhes; Virginie Eclache; Caroline Dartigeas; Pascal Turlure; Stephanie Harel; Celia Salanoubat; Jean-Jacques Kiladjian; Pierre Fenaux; Lionel Adès
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).
Blood 2010;116(19):3735-42.
2010: Pierre Fenaux; David Bowen; Norbert Gattermann; Eva Hellström-Lindberg; Wolf-Karsten Hofmann; Michael Pfeilstöcker; Guillermo Sanz; Valeria Santini
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.
Leukemia research 2010;34(11):1410-6.
2010: Sophie Park; Charikleia Kelaidi; Rosa Sapena; Dominique Vassilieff; Odile Beyne-Rauzy; Valérie Coiteux; Norbert Vey; C Ravoet; Stéphane Cheze; Christian Rose; Laurence Legros; Aspasia Stamatoullas; Martine Escoffre-Barbe; Agnès Guerci; Marie-Pierre Chaury; Pierre Fenaux; François Dreyfus
Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients.
Leukemia research 2010;34(11):1430-6.
2010: Laurent Orsi; Alain Monnereau; Brigitte Dananche; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noel Milpied; Michel Leporrier; Denis Hemon; Xavier Troussard; Jacqueline Clavel
Occupational exposure to organic solvents and lymphoid neoplasms in men: results of a French case-control study.
Occupational and environmental medicine 2010;67(10):664-72.
2010: Norbert Gattermann; Carlo Finelli; Matteo Della Porta; Pierre Fenaux; Arnold Ganser; Agnes Guerci-Bresler; Mathias Schmid; Kerry Taylor; Dominique Vassilieff; Dany Habr; Gabor Domokos; Bernard Roubert; Christian Rose
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study.
Leukemia research 2010;34(9):1143-50.
2010: Olivier Nibourel; Olivier Kosmider; Meyling Cheok; Nicolas Boissel; Aline Renneville; Noël Philippe; Hervé Dombret; François Dreyfus; Bruno Quesnel; Sandrine Geffroy; Samuel Quentin; Catherine Roche-Lestienne; Jean-Michel Cayuela; Christophe Roumier; Pierre Fenaux; William Vainchenker; Olivier A Bernard; Jean Soulier; Michaëla Fontenay; Claude Preudhomme
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
Blood 2010;116(7):1132-5.
2010: Valeria Santini; Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Lewis R Silverman; Alan List; Steven D Gore; John F Seymour; Jay Backstrom; Charles L Beach
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.
European journal of haematology 2010;85(2):130-8.
2010: Christian Rose; Sabine Brechignac; Dominique Vassilief; Laurent Pascal; Aspasia Stamatoullas; Agnès Guerci; Dalila Larbaa; François Dreyfus; Odile Beyne-Rauzy; Marie Pierre Chaury; Lydie Roy; Stephane Cheze; Pierre Morel; Pierre Fenaux
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).
Leukemia research 2010;34(7):864-70.
2010: Charikleia Kelaidi; Aspasia Stamatoullas; Odile Beyne-Rauzy; Emmanuel Raffoux; Bruno Quesnel; Agnès Guerci; François Dreyfus; Sabine Brechignac; Christian Berthou; Thomas Prebet; Yosr Hicheri; Maya Hacini; Jacques Delaunay; Marie-Pierre Gourin; Jean-Marie Camo; Hacene Zerazhi; Anne-Laure Taksin; Laurence Legros; Bachra Choufi; Pierre Fenaux
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies.
Haematologica 2010;95(6):892-9.
2010: Emmanuel Raffoux; Audrey Cras; Christian Recher; Pierre-Yves Boëlle; Adrienne de Labarthe; Pascal Turlure; Jean-Pierre Marolleau; Oumedaly Reman; Claude Gardin; Maud Victor; Sébastien Maury; Philippe Rousselot; Jean-Valère Malfuson; Odile Maarek; Marie-Thérèse Daniel; Pierre Fenaux; Laurent Degos; Christine Chomienne; Sylvie Chevret; Hervé Dombret
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.
Oncotarget 2010;1(1):34-42.
2010: Pierre Fenaux; Norbert Gattermann; John F Seymour; Eva Hellström-Lindberg; Ghulam J Mufti; Ulrich Duehrsen; Steven D Gore; Fernando Ramos; Odile Beyne-Rauzy; Alan List; David McKenzie; Jay Backstrom; Charles L Beach
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
British journal of haematology 2010;149(2):244-9.
2010: Ramzi Jeddi; Hèla Ghédira; Samia Mnif; Emna Gouider; Pierre Fenaux; Balkis Meddeb
High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia.
Leukemia research 2010;34(4):545-7.
2010: Lionel Adès; Agnès Guerci; Emmanuel Raffoux; M Sanz; Patrice Chevallier; Simona Lapusan; Christian Recher; Xavier Thomas; C Rayon; Sylvie Castaigne; Olivier Tournilhac; Stéphane de Botton; Norbert Ifrah; Jean-Yves Cahn; Eric Solary; Claude Gardin; Nathalie Fegeux; Dominique Bordessoule; Augustin Ferrant; Sandrine Meyer-Monard; Norbert Vey; Hervé Dombret; Laurent Degos; Sylvie Chevret; Pierre Fenaux
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.
Blood 2010;115(9):1690-6.
2010: Cecile Pautas; Fatiha Merabet; Xavier Thomas; Emmanuel Raffoux; Claude Gardin; Selim Corm; Jean-Henri Bourhis; Oumedaly Reman; Pascal Turlure; Nathalie Contentin; Thierry de Revel; Philippe Rousselot; Claude Preudhomme; Dominique Bordessoule; Pierre Fenaux; Christine Terré; Mauricette Michallet; Hervé Dombret; Sylvie Chevret; Sylvie Castaigne
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):808-14.
2010: Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Ulrich Germing; Guillermo Sanz; Alan F List; Steven D Gore; John F Seymour; Hervé Dombret; Jay Backstrom; Linda Zimmerman; David McKenzie; C L Beach; Lewis R Silverman
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):562-9.
2010: Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo Coco; Tomoki Naoe; Dietger Niederwieser; Gert Ossenkoppele; MA Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Blood 2010;115(3):453-74.
2010: Andrew Lamb; Pierre Fenaux; Mikkael A Sekeres; Pamela S Becker; Adam Boruchov; David Bowen; Eva Hellstrom-Lindberg; Richard A Larson; Roger M Lyons; Petra Muus; Jamile Shammo; Robert Siegel; Kuolung Hu; Janet Franklin; Dietmar P Berger
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):437-44.
2010: Nathalie M Droin; Arnaud Jacquel; Jean-Baptiste Hendra; Cindy Racoeur; Caroline Truntzer; Delphine Pecqueur; Naïma Benikhlef; Marion Ciudad; Leslie Guery; Valérie Jooste; Erick Dufour; Pierre Fenaux; Bruno Quesnel; Olivier Kosmider; Michaëla Fontenay; Patrick Ducoroy; Eric Solary
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia.
Blood 2010;115(1):78-88.
2009: Olivier Fain; Magdalena Gérin; Tewfik Bibi-Triki; Thorsten Braun; Pierre Fenaux
[Relapsing polychondritis and chronic myelomonocytic leukemia].
La Revue du praticien 2009;59(10):1350.
2009: Pierre Fenaux; Christian Rose
Impact of iron overload in myelodysplastic syndromes.
Blood reviews 2009;23 Suppl 1():S15-9.
2009: Pierre Fenaux; Lionel Ades
Review of azacitidine trials in Intermediate-2-and High-risk myelodysplastic syndromes.
Leukemia research 2009;33 Suppl 2():S7-11.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Marion Ciudad; Cindy Racoeur; Valérie Jooste; Norbert Vey; Bruno Quesnel; Pierre Fenaux; Jean-Noël Bastie; Odile Beyne-Rauzy; Aspasia Stamatoulas; François Dreyfus; Norbert Ifrah; Stéphane de Botton; William Vainchenker; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay; Eric Solary
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Haematologica 2009;94(12):1676-81.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Meyling Cheok; Sophie Grabar; Véronique Della Valle; Françoise Picard; Franck Viguié; Bruno Quesnel; Odile Beyne-Rauzy; Eric Solary; Norbert Vey; Mathilde Hunault-Berger; Pierre Fenaux; Véronique Mansat-De Mas; Eric Delabesse; Philippe Guardiola; Catherine Lacombe; William Vainchenker; Claude Preudhomme; François Dreyfus; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Blood 2009;114(15):3285-91.
2009: Thomas Clozel; Aline Renneville; Marion Venot; Claude Gardin; Charikleia Kelaidi; Geneviève Leroux; Virginie Eclache; Claude Preudhomme; Pierre Fenaux; Lionel Adès
Slow relapse in acute myeloid leukemia with inv(16) or t(16;16).
Haematologica 2009;94(10):1466-8.
2009: Bruno Cassinat; Stéphane de Botton; Charikleia Kelaidi; Lionel Ades; Fabien Zassadowski; Isabelle Guillemot; Marie-Helene Schlageter; Emmanuel Raffoux; Jean-Luc Harousseau; Ollivier Legrand; Martine Escoffre-Barbe; Oumedaly Reman; Martine Gardembas; Chantal Himberlin; Jean Yves Cahn; Denis Guyotat; Didier Bouscary; Anne Parry; Philippe Rousselot; Andre Baruchel; Hervé Dombret; Sylvie Chevret; Pierre Fenaux; Christine Chomienne
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Leukemia research 2009;33(9):1178-82.
2009: Simone Boehrer; L Adès; Nicolas Tajeddine; W K Hofmann; S Kriener; G Bug; O G Ottmann; M Ruthardt; Lorenzo Galluzzi; C Fouassier; M Tailler; K A Olaussen; C Gardin; V Eclache; Stéphane de Botton; S Thepot; Pierre Fenaux; Guido Kroemer
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.
Oncogene 2009;28(22):2205-18.
2009: Charikleia Kelaidi; Sylvie Chevret; Stéphane de Botton; Emmanuel Raffoux; Agnès Guerci; Xavier Thomas; Arnaud Pigneux; Thierry Lamy; Françoise Rigal-Huguet; Sandrine Meyer-Monard; Patrice Chevallier; Frédéric Maloisel; Erick Deconinck; Augustin Ferrant; Nathalie Fegueux; Norbert Ifrah; Miguel Sanz; Hervé Dombret; Pierre Fenaux; Lionel Adès
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2668-76.
2009: Lionel Adès; Simone Boehrer; Thomas Prebet; Odile Beyne-Rauzy; Laurence Legros; Christophe Ravoet; François Dreyfus; Aspasia Stamatoullas; Marie Pierre Chaury; Jacques Delaunay; Guy Laurent; Norbert Vey; Sara Burcheri; Rose-Marie Mbida; Natacha Hoarau; Claude Gardin; Pierre Fenaux
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
Blood 2009;113(17):3947-52.
2009: J Tamburini; C Elie; Sophie Park; Odile Beyne-Rauzy; Martine Gardembas; Christian Berthou; Béatrice Mahe; L Sanhes; Aspasia Stamatoullas; Norbert Vey; Achille Aouba; B Slama; B Quesnel; A Vekhoff; J J Sotto; Dominique Vassilief; C Al-Nawakil; Pierre Fenaux; François Dreyfus; Didier Bouscary
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
Leukemia research 2009;33(4):547-50.
2009: Raphael Itzykson; Pierre Fenaux
Optimal sequencing of treatments for patients with myelodysplastic syndromes.
Current opinion in hematology 2009;16(2):77-83.
2009: Pierre Fenaux; Ghulam J Mufti; Eva Hellstrom-Lindberg; Valeria Santini; Carlo Finelli; Aristoteles Giagounidis; Robert Schoch; Norbert Gattermann; Guillermo Sanz; Alan List; Steven D Gore; John F Seymour; john bennett; John Byrd; Jay Backstrom; Linda Zimmerman; David McKenzie; Cl Beach; Lewis R Silverman
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The lancet oncology 2009;10(3):223-32.
2009: J Grosjean-Raillard; M Tailler; L Adès; Jean-Luc PERFETTINI; Claire Fabre; Thorsten Braun; Stéphane de Botton; Pierre Fenaux; Guido Kroemer
ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2009;28(8):1099-109.
2009: Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo Coco
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2009;113(9):1875-91.
2009: Agota Szende; Caroline Schaefer; Thomas F Goss; Kathy Heptinstall; Robert Knight; Michael Lübbert; Barbara Deschler; Pierre Fenaux; Ghulam J Mufti; Sally Killick; Alan F List
Valuation of transfusion-free living in MDS: results of health utility interviews with patients.
Health and quality of life outcomes 2009;7():81.
2008: Simone Boehrer; Lionel Adès; Lorenzo Galluzzi; Nicolas Tajeddine; Maximilien Tailler; Claude Gardin; Stéphane de Botton; Pierre Fenaux; Guido Kroemer
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison.
Biochemical pharmacology 2008;76(11):1417-25.
2008: Abir Gmidène; Hlima Sennana; Pierre Fenaux; Adnène Laatiri; Mohamed Zarrouk; Houssem Bouaziz; Imed Harrabi; Ali Saad
Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
Leukemia research 2008;32(12):1824-9.
2008: Ghulam J Mufti; john bennett; Jean Goasguen; Barbara J Bain; Irith Baumann; Richard Brunning; Mario Cazzola; Pierre Fenaux; Ulrich Germing; Eva Hellström-Lindberg; Itsuro Jinnai; Atsushi Manabe; Akira Matsuda; Charlotte M Niemeyer; Guillermo Sanz; Masao Tomonaga; Teresa Vallespi; Ayami Yoshimi
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Haematologica 2008;93(11):1712-7.
2008: Jean-Jacques Kiladjian; Bruno Cassinat; Sylvie Chevret; Pascal Turlure; Nathalie Cambier; Murielle Roussel; Sylvia Bellucci; Bernard Grandchamp; Christine Chomienne; Pierre Fenaux
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera.
Blood 2008;112(8):3065-72.
2008: Andrew Lamb; Susan O'Brien; Farhad Ravandi; Jorge Cortes; Jianqin Shan; John M Bennett; Alan F List; Pierre Fenaux; Guillermo Sanz; Jean-Pierre J Issa; Emil J Freireich; Guillermo Garcia-Manero
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
Cancer 2008;113(6):1351-61.
2008: Jennifer Grosjean-Raillard; Lionel Adès; Simone Boehrer; Maximilien Tailler; Claire Fabre; Thorsten Braun; Stéphane de Botton; Alain Israel; Pierre Fenaux; Guido Kroemer
Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Apoptosis : an international journal on programmed cell death 2008;13(9):1148-61.
2008: Fabien Zassadowski; Lionel Ades; Marie-Helene Schlageter; Sylvie Chevret; Isabelle Guillemot; Pierre Fenaux; Christine Chomienne; Bruno Cassinat
Auer rods and differentiation in acute promyelocytic leukemia.
British journal of haematology 2008;142(6):998-1000.
2008: Bertrand Godeau; Raphael Porcher; Olivier Fain; François Lefrère; Pierre Fenaux; Stéphane Cheze; Anne Vekhoff; Marie-Paule Chauveheid; Jerôme Stirnemann; Lionel Galicier; Emmanuelle Bourgeois; Stéphanie Haiat; Bruno Varet; Michel Leporrier; Thomas Papo; Mehdi Khellaf; Marc Michel; Philippe Bierling
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
Blood 2008;112(4):999-1004.
2008: Eirini Kouroupi; Katerina Zoi; Nathalie Parquet; Christine Zoi; Jean-Jacques Kiladjian; Vassiliki Grigoraki; William Vainchenker; Franck Lellouche; Christophe Marzac; Marie-Hélène Schlageter; Christine Dosquet; Linda Maree SCOTT; Pierre Fenaux; Dimitris Loukopoulos; Christine Chomienne; Bruno Cassinat
Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
British journal of haematology 2008;142(4):676-9.
2008: Claire Fabre; Jennifer Grosjean; Maximilien Tailler; Simone Boehrer; Lionel Adès; Jean-Luc PERFETTINI; Stéphane de Botton; Pierre Fenaux; Guido Kroemer
A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts.
Cell cycle (Georgetown, Tex.) 2008;7(14):2139-45.
2008: Jean-Jacques Kiladjian; Francisco Cervantes; Franck W G Leebeek; Christophe Marzac; Bruno Cassinat; Sylvie Chevret; Dominique Cazals-Hatem; Aurélie Plessier; Juan Carlos Garcia-Pagan; Sarwa Darwish Murad; Sebastian Raffa; Harry L A Janssen; Claude Gardin; Sophie Cereja; Carole Tonetti; Stéphane Giraudier; Bertrand Condat; Nicole Casadevall; Pierre Fenaux; Dominique C Valla
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
Blood 2008;111(10):4922-9.
2008: Thorsten Braun; Pierre Fenaux
Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2008;141(5):576-86.
2008: Aristoteles Giagounidis; Pierre Fenaux; Ghulam J Mufti; Petra Muus; Uwe Platzbecker; Guillermo Sanz; Larry Cripe; Marie von Lilienfeld-Toal; Richard A Wells
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.
Annals of hematology 2008;87(5):345-52.
2008: David T Bowen; Pierre Fenaux; Eva Hellstrom-Lindberg; Theo de Witte
Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1180; author reply 1181-2.
2008: Jean-Jacques Kiladjian; Géraldine Visentin; Emilie Viey; Sylvie Chevret; Virginie Eclache; Jerome Stirnemann; Jean-Henri Bourhis; Salem Chouaib; Pierre Fenaux; Anne Caignard
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
Haematologica 2008;93(3):381-9.
2008: Simone Boehrer; Lionel Adès; Thorsten Braun; Lorenzo Galluzzi; Jennifer Grosjean; Claire Fabre; Génèviève Le Roux; Claude Gardin; Antoine Martin; Stéphane de Botton; Pierre Fenaux; Guido Kroemer
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study.
Blood 2008;111(4):2170-80.
2008: Virginie Eclache; Anna Da Rocha; Génevieve Le Roux; Pierre Fenaux
Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide.
Haematologica 2008;93(2):315-6.
2008: Charikleia Kelaidi; Virginie Eclache; Pierre Fenaux
The role of lenalidomide in the management of myelodysplasia with del 5q.
British journal of haematology 2008;140(3):267-78.
2008: Lionel Adès; Miguel A Sanz; Sylvie Chevret; Pau Montesinos; Patrice Chevallier; Emmanuel Raffoux; Edo Vellenga; Agnès Guerci; Arnaud Pigneux; Francoise Huguet; C Rayon; Anne-Marie Stoppa; Javier de la Serna; Jean-Yves Cahn; Sandrine Meyer-Monard; Thomas Pabst; Xavier Thomas; Stéphane de Botton; Ricardo Parody; Juan Bergua; Thierry Lamy; Anne Vekhoff; Silvia Negri; Norbert Ifrah; Hervé Dombret; Augustin Ferrant; Dominique Bron; Laurent Degos; Pierre Fenaux
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
Blood 2008;111(3):1078-84.
2008: Bruno Cassinat; C Laguillier; Claude Gardin; V de Beco; S Burcheri; Pierre Fenaux; Christine Chomienne; Jean-Jacques Kiladjian
Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?
Leukemia 2008;22(2):452-3.
2008: Sophie Park; Sophie Grabar; Charikleia Kelaidi; Odile Beyne-Rauzy; Françoise Picard; Valérie Bardet; Valérie Coiteux; Geneviève Leroux; Pascale Lepelley; Marie-Thérèse Daniel; Stéphane Cheze; Béatrice Mahé; Augustin Ferrant; C Ravoet; Martine Escoffre-Barbe; Lionel Adès; Norbert Vey; Lina Aljassem; Aspasia Stamatoullas; Lionel Mannone; Hervé Dombret; Keith Bourgeois; Peter Greenberg; Pierre Fenaux; François Dreyfus
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
Blood 2008;111(2):574-82.
2008: Pierre Fenaux; Norbert Gattermann; Eva Hellström-Lindberg; D McKenzie; V Santini; G Sanz; L Zimmerman; C L Beach; Steven D Gore; A F List; G J Mufti; J F Seymour; J Backstrom; L B Silverman
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.
Ecancermedicalscience 2008;2():121.
2008: L R Silverman; Steven D Gore; A F List; G J Mufti; J F Seymour; J Backstrom; Pierre Fenaux; Norbert Gattermann; Eva Hellström-Lindberg; D McKenzie; V Santini; G Sanz; C L Beach
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.
Ecancermedicalscience 2008;2():118.
2008: Mathieu Capovilla; Jean-Michel Cayuela; Chrystèle Bilhou-Nabera; Claude Gardin; Remi Letestu; Fanny Baran-Marzak; Pierre Fenaux; Antoine Martin
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy.
European journal of haematology 2008;80(1):81-6.
2007: Nader Omidvar; Scott C Kogan; Stephanie Beurlet; Carole le Pogam; Anne Janin; Robert R West; Maria-Elena Noguera; Murielle Reboul; Annie Soulie; Christophe Leboeuf; Niclas Setterblad; Dean W Felsher; Eric Lagasse; Azim Mohamedali; N Shaun B Thomas; Pierre Fenaux; Michaela Fontenay; Marika Pla; Ghulam J Mufti; Irving Weissman; Christine Chomienne; Rose Ann Padua
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
Cancer research 2007;67(24):11657-67.
2007: laurent orsi; Xavier Troussard; Alain Monnereau; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noel Milpied; Michel Leporrier; Denis Hemon; Jacqueline Clavel
Occupation and lymphoid malignancies: results from a French case-control study.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2007;49(12):1339-50.
2007: Laurent Delva; Arthur Zelent; Tomoki Naoe; Pierre Fenaux; Samuel Waxman; Laurent Degos; Christine Chomienne
Meeting report: the 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology.
Cancer research 2007;67(22):10635-7.
2007: Jean-Jacques Kiladjian; Pierre Fenaux; Anne Caignard
Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromes.
Leukemia 2007;21(11):2237-9.
2007: Emmanuelle Tavernier; Jean-Michel Boiron; Francoise Huguet; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Jean-Paul Vernant; Hervé Dombret; Xavier Thomas
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia 2007;21(9):1907-14.
2007: Alain Monnereau; laurent orsi; Xavier Troussard; Christian Berthou; Pierre Fenaux; Gérald Marit; Pierre Soubeyran; Francoise Huguet; N Milpied; Michel Leporrier; D Hemon; J Clavel
History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk?
Leukemia 2007;21(9):2075-9.
2007: Jean-Luc Harousseau; Jeffrey E Lancet; Josy Reiffers; Bob Lowenberg; Xavier Thomas; Francoise Huguet; Pierre Fenaux; Steven Zhang; Wayne Rackoff; Peter De Porre; Richard Stone
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.
Blood 2007;109(12):5151-6.
2007: Claude Gardin; Pascal Turlure; Thierry Fagot; Xavier Thomas; Christine Terre; Nathalie Contentin; Emmanuel Raffoux; Stéphane de Botton; Cécile Pautas; Oumedaly Reman; Jean-Henri Bourhis; Pierre Fenaux; Sylvie Castaigne; Mauricette Michallet; Claude Preudhomme; Thierry de Revel; Dominique Bordessoule; Hervé Dombret
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
Blood 2007;109(12):5129-35.
2007: Claire Fabre; Gabrielle Carvalho; Ezgi Tasdemir; Thorsten Braun; L Adès; Jennifer Grosjean; Simone Boehrer; Didier Métivier; Sylvie Souquère; Gérard Pierron; Pierre Fenaux; Guido Kroemer
NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2007;26(28):4071-83.
2007: Thorsten Braun; Gabrielle Carvalho; Jennifer Grosjean; Lionel Ades; Claire Fabre; Simone Boehrer; Najet Debili; Pierre Fenaux; Guido Kroemer
Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation.
Apoptosis : an international journal on programmed cell death 2007;12(6):1101-8.
2007: Pierre Fenaux; Azra Raza; Ghulam J Mufti; Carlo Aul; Ulrich Germing; Andrew Lamb; Larry D Cripe; René Kerstens; Peter De Porre; Razelle Kurzrock
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.
Blood 2007;109(10):4158-63.
2007: Gabrielle Carvalho; Claire Fabre; Thorsten Braun; Jennifer Grosjean; L Ades; Fabrice Agou; Ezgi Tasdemir; Simone Boehrer; Alain Israel; Michel Véron; Pierre Fenaux; Guido Kroemer
Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2007;26(16):2299-307.
2007: Xavier Thomas; Emmanuel Raffoux; S de Botton; Cécile Pautas; Philippe Arnaud; Thierry de Revel; Oumedaly Reman; Christine Terré; B Corront; Claude Gardin; Quoc-Hung Le; Bruno Quesnel; Catherine Cordonnier; Jean-Henri Bourhis; Mohamed Elhamri; Pierre Fenaux; Claude Preudhomme; Mauricette Michallet; Sylvie Castaigne; Hervé Dombret
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Leukemia 2007;21(3):453-61.
2007: Jean-Jacques Kiladjian; Nicole Casadevall; William Vainchenker; Pierre Fenaux
The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disorders.
Pathologie-biologie 2007;55(2):85-7.
2007: Valérie Coiteux; Rosine Onclercq-Delic; Pierre Fenaux; Mounira Amor-Guéret
Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Leukemia research 2007;31(3):353-8.
2007: Marie-Cécile Le Deley; Florence Suzan; Bruno Cutuli; Suzette Delaloge; Akthar Shamsaldin; Claude Linassier; Stéphanie Clisant; Florent de Vathaire; Pierre Fenaux; Catherine Hill
Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):292-300.
2007: Pierre Fenaux; Z Z Wang; Laurent Degos
Treatment of acute promyelocytic leukemia by retinoids.
Current topics in microbiology and immunology 2007;313():101-28.
2006: Lionel Adès; Sylvie Chevret; Emmanuel Raffoux; Stéphane de Botton; Agnès Guerci; Arnaud Pigneux; Anne-Marie Stoppa; Thierry Lamy; Françoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; Frédéric Maloisel; Eric DECONINCK; Augustin Ferrant; Xavier Thomas; Nathalie Fegueux; Christine Chomienne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5703-10.
2006: Bruno Cassinat; Isabelle Guillemot; Cécile Moluçon-Chabrot; Fabien Zassadowski; Pierre Fenaux; Olivier Tournilhac; Christine Chomienne
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Haematologica 2006;91(12 Suppl):ECR58.
2006: Marie Robin; Juliette Andreu-Gallien; Marie-Hélène Schlageter; Djaouida Bengoufa; Isabelle Guillemot; Katerina Pokorna; Carine Robert; Jérôme Larghero; Philippe Rousselot; Emmanuel Raffoux; Hervé Dombret; Pierre Fenaux; Marika Pla; Dominique Charron; Rose Ann Padua; Christine Chomienne
Frequent antibody production against RARalpha in both APL mice and patients.
Blood 2006;108(6):1972-4.
2006: Jean-Jacques Kiladjian; Bruno Cassinat; Pascal Turlure; Nathalie Cambier; Murielle Roussel; Sylvia Bellucci; Marie-Laurence Menot; Gerald Massonnet; Jean-Luc Dutel; Kamel Ghomari; Philippe Rousselot; Marie-Jose Grange; Yasmina Chait; William Vainchenker; Nathalie Parquet; Lina Abdelkader-Aljassem; Jean-François Bernard; Jean-Didier Rain; Sylvie Chevret; Christine Chomienne; Pierre Fenaux
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.
Blood 2006;108(6):2037-40.
2006: Lionel Adès; Pierre Fenaux
Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
Clinical advances in hematology & oncology : H&O 2006;4(9):678-82.
2006: Xavier Thomas; Arnaud Pigneux; Emmanuel Raffoux; Francoise Huguet; Denis Caillot; Pierre Fenaux
Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
Haematologica 2006;91(7):996-7.
2006: Wendy Ingram; Nicholas C Lea; J Cervera; Ulrich Germing; Pierre Fenaux; Bruno Cassinat; Jean-Jacques Kiladjian; Judit Várkonyi; P Antunovic; Nigel B Westwood; Matthew Arno; Azim Mohamedali; J Gaken; T Kontou; Barbara Czepulkowski; N A Twine; J Tamaska; J Csomer; S Benedek; Norbert Gattermann; E Zipperer; Aristotle Giagounidis; Z Garcia-Casado; G Sanz; Ghulam J Mufti
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
Leukemia 2006;20(7):1319-21.
2006: Lionel Adès; Pierre Fenaux
Is cytarabine required in the treatment of acute promyelocytic leukemia?
Current hematologic malignancy reports 2006;1(2):122-5.
2006: Jean-Jacques Kiladjian; Jean-Didier Rain; Jean-François Bernard; Jean Briere; Christine Chomienne; Pierre Fenaux
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Seminars in thrombosis and hemostasis 2006;32(4 Pt 2):417-21.
2006: L Mannone; Claude Gardin; Marie C Quarre; Jean-François Bernard; D Vassilieff; L Ades; S Park; S Vaultier; F Hamza; M O Beyne-rauzy; S Cheze; Stéphane Giraudier; P Agape; Laurence Legros; L Voillat; François Dreyfus; Pierre Fenaux
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study.
British journal of haematology 2006;133(5):513-9.
2006: Norbert Vey; André Bosly; Agnès Guerci; Walter Feremans; Hervé Dombret; François Dreyfus; David Bowen; Alan Burnett; Mike Dennis; Vincent Ribrag; Nicole Casadevall; Laurence Legros; Pierre Fenaux
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2465-71.
2006: Jean-Jacques Kiladjian; N Elkassar; Bruno Cassinat; Gilles Hetet; Stéphane Giraudier; Nicole Balitrand; C Conejero; Jean Briere; Pierre Fenaux; Christine Chomienne; Bernard Grandchamp
Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.
Leukemia 2006;20(6):1181-3.
2006: C Kelaidi; Lionel Ades; Sylvie Chevret; M Sanz; Agnès Guerci; Xavier Thomas; Stéphane de Botton; Emmanuel Raffoux; C Rayon; Nathalie Fegueux; Dominique Bordessoule; Françoise Rigal-Huguet; H Link; Anne-Marie Stoppa; Anne Vekhoff; Sandrine Meyer-Monard; Sylvie Castaigne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
Leukemia 2006;20(5):905-7.
2006: Thorsten Braun; Gabrielle Carvalho; Claire Fabre; Jennifer Grosjean; Pierre Fenaux; Guido Kroemer
Targeting NF-kappaB in hematologic malignancies.
Cell death and differentiation 2006;13(5):748-58.
2006: Sophie Ducastelle; Lionel Adès; Claude Gardin; Hervé Dombret; Thomas Prébet; Eric DECONINCK; Bernard Rio; Xavier Thomas; Stephan Debotton; Agnès Guerci; Nicole Gratecos; Aspasia Stamatoullas; Nathalie Fegueux; François Dreyfus; Pierre Fenaux; Eric Wattel
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Haematologica 2006;91(3):373-6.
2006: Christophe Roumier; S Lejeune-Dumoulin; Aline Renneville; A S Goethgeluck; Noël Philippe; Pierre Fenaux; Claude Preudhomme
Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
Leukemia 2006;20(3):433-6.
2006: Jean-Jacques Kiladjian; E Bourgeois; I Lobe; Thorsten Braun; G Visentin; Jean-Henri Bourhis; Pierre Fenaux; S Chouaib; Anne Caignard
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.
Leukemia 2006;20(3):463-70.
2006: Peter J Campbell; Martin Griesshammer; Konstanze Döhner; Hartmut Döhner; Rajko Kusec; Hans Carl Hasselbalch; Thomas Stauffer Larsen; Niels Pallisgaard; Stéphane Giraudier; Marie-Caroline Le Bousse-Kerdilès; desterke christophe; Bernadette Guerton; Brigitte Dupriez; Dominique Bordessoule; Pierre Fenaux; Jean-Jacques Kiladjian; Jean-François Viallard; Josette Brière; Claire N Harrison; Anthony R Green; John T Reilly
V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.
Blood 2006;107(5):2098-100.
2006: Thorsten Braun; Gabrielle Carvalho; Arnaud Coquelle; Marie-Catherine Vozenin; Pascale Lepelley; François Hirsch; Jean-Jacques Kiladjian; Vincent Ribrag; Pierre Fenaux; Guido Kroemer
NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome.
Blood 2006;107(3):1156-65.
2006: Pierre Fenaux; Charikleia Kelaidi
Treatment of the 5q- syndrome.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():192-8.
2006: Stéphane de Botton; M A Sanz; Sylvie Chevret; Hervé Dombret; G Martin; Xavier Thomas; J D Mediavilla; Christian Recher; Lionel Ades; Bruno Quesnel; P Brault; Martin Fey; H Wandt; D Machover; Agnès Guerci; Frédéric Maloisel; Anne-Marie Stoppa; C Rayon; J M Ribera; Christine Chomienne; Laurent Degos; Pierre Fenaux
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Leukemia 2006;20(1):35-41.
2005: Didier Bouscary; Laurence Legros; Micheline Tulliez; Stéphanie Dubois; Béatrice Mahe; Odile Beyne-Rauzy; Marie C Quarre; Dominique Vassilief; Bruno Varet; Achille Aouba; Martine Gardembas; Stéphane Giraudier; Agnès Guerci; Philippe Rousselot; Fanny Gaillard; Anne Moreau; Marie-Christine Rousselet; Norbert Ifrah; Pierre Fenaux; François Dreyfus
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies.
British journal of haematology 2005;131(5):609-18.
2005: Pierre Fenaux
Inhibitors of DNA methylation: beyond myelodysplastic syndromes.
Nature clinical practice. Oncology 2005;2 Suppl 1():S36-44.
2005: Claude Gardin; Pierre Fenaux
[Dysmyelopoeisis].
La Revue du praticien 2005;55(17):1957-61.
2005: Nicolas Boissel; Aline Renneville; Valeria Biggio; Noël Philippe; Xavier Thomas; Jean-Michel Cayuela; Christine Terre; Isabelle Tigaud; Sylvie Castaigne; Emmanuel Raffoux; Stéphane de Botton; Pierre Fenaux; Hervé Dombret; Claude Preudhomme
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Blood 2005;106(10):3618-20.
2005: Miguel A Sanz; Pierre Fenaux; Francesco Lo Coco
Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence.
Haematologica 2005;90(9):1231-5.
2005: Pierre Fenaux
Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).
Seminars in oncology 2005;32(4 Suppl 5):S11-5.
2005: Xavier Thomas; Qh Le; S de Botton; Emmanuel Raffoux; Youcef Chelghoum; Cécile Pautas; François Dreyfus; Nathalie Dhedin; Anne Vekhoff; Jacques Troncy; Arnaud Pigneux; T de Revel; Oumedaly Reman; Philippe Travade; Anne Thiebaut; Agnès Guerci; Mohamed Elhamri; Pierre Fenaux; Hervé Dombret; Mauricette Michallet
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
Leukemia & lymphoma 2005;46(7):1007-16.
2005: C Callens; Sylvie Chevret; Jean-Michel Cayuela; Bruno Cassinat; Emmanuel Raffoux; Stéphane de Botton; Xavier Thomas; Agnès Guerci; Nathalie Fegueux; Arnaud Pigneux; Anne-Marie Stoppa; Thierry Lamy; Françoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; A Ferrand; M Sanz; Christine Chomienne; Pierre Fenaux; Hervé Dombret
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Leukemia 2005;19(7):1153-60.
2005: Jérôme Cornillon; Abir Fawaz; Stéphane Depil; Françoise Dufosse; Alain Duhamel; Francis Bauters; Pierre Fenaux; Jean-Pierre Jouet; Ibrahim Yakoub-Agha
Outcome of patients less than 55 years of age with high-risk acute leukemia who did not have an human leukocyte antigen-identical related donor: a long-term study of 97 consecutive patients.
Leukemia & lymphoma 2005;46(6):841-9.
2005: Leroy Hugues; Hélène Cavé; Nathalie Philippe; Sabrina Pereira; Pierre Fenaux; Claude Preudhomme
Mutations of PTPN11 are rare in adult myeloid malignancies.
Haematologica 2005;90(6):853-4.
2005: Jean-Jacques Kiladjian; Jean-François Bernard; Pierre Fenaux
Is life expectancy of polycythemia vera patients clearly different from that of the general population?
The American journal of medicine 2005;118(5):565; author reply 565-6.
2005: Virginie Eclache; Franck Viguie; Claudie Frocrain; Bruno Cassinat; Christine Chomienne; Florence Cymbalista; Pierre Fenaux
A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
Cancer genetics and cytogenetics 2005;159(1):69-73.
2005: Catherine Roche-Lestienne; S Lepers; Valérie Soenen-Cornu; Jean-Emmanuel Kahn; Jean-Luc Laï; E Hachulla; F Drupt; A-L Demarty; Anne Roumier; Martine Gardembas; M Dib; Noël Philippe; Nathalie Cambier; S Barete; C Libersa; Olivier Bletry; Pierre-Yves Hatron; Bruno Quesnel; Christian Rose; K Maloum; Odile Blanchet; Pierre Fenaux; Lionel Prin; Claude Preudhomme
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
Leukemia 2005;19(5):792-8.
2005: Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
The New England journal of medicine 2005;352(15):1529-38.
2005: Valérie Soenen-Cornu; Cristina Tourino; Marie-Laure Bonnet; Martine Guillier; Stéphane Flamant; Rami Kotb; Alain BERNHEIM; Jean-Henri Bourhis; Claude Preudhomme; Pierre Fenaux; Ali G Turhan
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Oncogene 2005;24(15):2441-8.
2005: Adrienne de Labarthe; Cécile Pautas; Xavier Thomas; Stéphane de Botton; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Christian Bastard; Claude Preudhomme; Mauricette Michallet; Pierre Fenaux; Jean-Noël Bastie; Gérard Socié; Catherine Cordonnier; Hervé Dombret
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Bone marrow transplantation 2005;35(8):767-73.
2005: Emmanuelle Barouk-Simonet; Valérie Soenen-Cornu; Christophe Roumier; Alain Cosson; Jean-Luc Laï; Pierre Fenaux; Claude Preudhomme
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
Cancer genetics and cytogenetics 2005;157(2):118-26.
2005: Hugues Leroy; Stéphane de Botton; Nathalie Grardel-Duflos; Stéphane Darre; Xavier Leleu; Christophe Roumier; Franck Morschhauser; Jean-Luc Lai; Francis Bauters; Pierre Fenaux; Claude Preudhomme
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
Leukemia 2005;19(3):367-72.
2005: Hugues Leroy; Christophe Roumier; Pauline Huyghe; Valeria Biggio; Pierre Fenaux; Claude Preudhomme
CEBPA point mutations in hematological malignancies.
Leukemia 2005;19(3):329-34.
2005: Lionel Ades; Sylvie Chevret; Stéphane de Botton; Xavier Thomas; Hervé Dombret; B Beve; M Sanz; Agnès Guerci; JS Miguel; J Dela Serna; C Garo; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.
Leukemia 2005;19(2):230-3.
2005: Stéphane de Botton; A Fawaz; Sylvie Chevret; Hervé Dombret; Xavier Thomas; M Sanz; Agnès Guerci; Jesús San Miguel; Javier de la Serna; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):120-6.
2004: Claude Gardin; Pierre Fenaux
Supportive care including growth factors in myelodysplastic syndromes.
Reviews in clinical and experimental hematology 2004;8(2):E3.
2004: Xavier Thomas; Jean-Michel Boiron; Francoise Huguet; Hervé Dombret; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Jean-Paul Vernant; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Denis Fiere
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4075-86.
2004: Sylvie Castaigne; Sylvie Chevret; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Marc Simon; Brigitte Dupriez; Michel Renoux; Maud Janvier; Jean-Michel Micléa; Xavier Thomas; Christian Bastard; Claude Preudhomme; Francis Bauters; Laurent Degos; Hervé Dombret
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Nicole Casadevall; Pierre Durieux; Stéphanie Dubois; François Hemery; Eric Lepage; Marie-Catherine Quarré; Gandhi Damaj; Stéphane Giraudier; Agnès Guerci; Guy Laurent; Hervé Dombret; Christine Chomienne; Vincent Ribrag; Aspasia Stamatoullas; Jean-Pierre Marie; Anne Vekhoff; Frédéric Maloisel; Robert Navarro; François Dreyfus; Pierre Fenaux
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.
Blood 2004;104(2):321-7.
2004: Stéphane de Botton; Valérie Coiteux; Sylvie Chevret; C Rayon; E Vilmer; M Sanz; Javier de la Serna; Noël Philippe; André Baruchel; G Leverger; A Robert; Jesús San Miguel; Eulogio Conde; Jean-Jacques Sotto; Dominique Bordessoule; Nathalie Fegueux; Martin Fey; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1404-12.
2004: Pierre Fenaux
Myelodysplastic syndromes: From pathogenesis and prognosis to treatment.
Seminars in hematology 2004;41(2 Suppl 4):6-12.
2004: Thomas Prébet; Sophie Ducastelle; Stephan Debotton; Aspasia Stamatoullas; Eric DECONINCK; Christophe Fruchart; Nicole Gratecos; Norbert Ifrah; François Dreyfus; Pierre Fenaux; Eric Wattel
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(3):209-15.
2004: Pauline Huyghe; Laurent Dassonneville; Pierre Fenaux; Christian Bailly
Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cell line.
Oncology research 2004;14(4-5):235-45.
2003: Pierre Fenaux; Sylvie Chevret; Stéphane de Botton
Treatment of older adults with acute promyelocytic leukaemia.
Best practice & research. Clinical haematology 2003;16(3):495-501.
2003: I Lobe; Françoise Rigal-Huguet; Anne Vekhoff; Bernard Desablens; Dominique Bordessoule; C Mounier; Augustin Ferrant; M Sanz; Martin Fey; Christine Chomienne; Sylvie Chevret; Laurent Degos; Pierre Fenaux
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
Leukemia 2003;17(8):1600-4.
2003: Jacques Delaunay; Norbert Vey; Thierry Leblanc; Pierre Fenaux; Françoise Rigal-Huguet; Francis Witz; Thierry Lamy; Anne Auvrignon; Didier Blaise; Arnaud Pigneux; Francine Mugneret; Christian Bastard; Nicole Dastugue; Jacqueline van den Akker; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Hervé Dombret
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Blood 2003;102(2):462-9.
2003: M Beaumont; M Sanz; P M Carli; Frédéric Maloisel; Xavier Thomas; L Detourmignies; Agnès Guerci; Nicole Gratecos; C Rayon; Jesús San Miguel; Jesús Odriozola; Jean-Yves Cahn; Francoise Huguet; A Vekhof; A Stamatoulas; Hervé Dombret; Francisco J Capote; Jordi Esteve; Anne-Marie Stoppa; Pierre Fenaux
Therapy-related acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2123-37.
2003: Vincent Ribrag; serge koscielny; I Carpiuc; C Cebotaru; H Vande Walle; M Talbot; Pierre Fenaux; Jacques Bosq
Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
Leukemia 2003;17(5):972-7.
2003: Emmanuelle Bourgeois; Marie Thérèse Caulier; Catherine Delarozee; Marc Brouillard; Francis Bauters; Pierre Fenaux
Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis.
British journal of haematology 2003;120(6):1079-88.
2003: Christophe Roumier; Virginie Eclache; Michèle Imbert; Frédéric Davi; Elizabeth Macintyre; Richard Garand; Pascaline Talmant; Pascale Lepelley; Jean-Luc Lai; Olivier Casasnovas; Marc Maynadie; Francine Mugneret; Chrystele Bilhou-Naberra; Françoise Valensi; Isabelle Radford; Marie-Joëlle Mozziconacci; Christine Arnoulet; Eliane Duchayne; Nicole Dastugue; Pascale Cornillet; Sylvie Daliphard; Francine Garnache; Najiba Boudjerra; Hélène Jouault; Odile Fenneteau; Béatrice Pedron; Roland Berger; Georges Flandrin; Pierre Fenaux; Claude Preudhomme
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
Blood 2003;101(4):1277-83.
2003: Stéphane de Botton; Sylvie Chevret; Valérie Coiteux; Hervé Dombret; M Sanz; Jesús San Miguel; Denis Caillot; Anne Vekhoff; Martine Gardembas; A Stamatoulas; Eulogio Conde; Agnès Guerci; Claude Gardin; Martin Fey; D Cony Makhoul; Oumedaly Reman; Javier de la Serna; F Lefrere; Christine Chomienne; Laurent Degos; Pierre Fenaux
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
Leukemia 2003;17(2):339-42.
2003: Vincent Ribrag; Florence Suzan; C Ravoet; Walter Feremans; Agnès Guerci; François Dreyfus; Gandhi Damaj; Jean-Marie Vantelon; Jean-Henri Bourhis; Pierre Fenaux
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
Leukemia 2003;17(2):319-22.
2003: Rodolphe Vereecque; Aurore Saudemont; Thomas Wickham; Ricardo Gonzalez; Dominique Hetuin; Pierre Fenaux; Bruno Quesnel
Gamma-irradiation enhances transgene expression in leukemic cells.
Gene therapy 2003;10(3):227-33.
2003: Christophe Roumier; Pierre Fenaux; Marina Lafage; Michèle Imbert; Virginie Eclache; Claude Preudhomme
New mechanisms of AML1 gene alteration in hematological malignancies.
Leukemia 2003;17(1):9-16.
2002: Pierre Fenaux
[ Myelodysplastic syndrome].
La Revue du praticien 2002;52(20):2301-8.
2002: Charlotte Lamandin; Christophe Sagot; Christophe Roumier; Pascale Lepelley; Stéphane de Botton; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?
Blood 2002;100(13):4680-1.
2002: Claude Preudhomme; Christophe Sagot; Nicolas Boissel; Jean-Michel Cayuela; Isabelle Tigaud; Stéphane de Botton; Xavier Thomas; Emmanuel Raffoux; Charlotte Lamandin; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
Blood 2002;100(8):2717-23.
2002: Hervé Dombret; Jean Gabert; Jean-Michel Boiron; Françoise Rigal-Huguet; Didier Blaise; Xavier Thomas; André Delannoy; Agnès Buzyn; Chrystèle Bilhou-Nabera; Jean-Michel Cayuela; Pierre Fenaux; Jean-Henri Bourhis; Nathalie Fegueux; Christiane Charrin; Claude Boucheix; Véronique Lhéritier; Hélène Espérou; Elizabeth Macintyre; Jean-Paul Vernant; Denis Fière
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Blood 2002;100(7):2357-66.
2002: Stéphane Depil; Valérie Coiteux; Gaëlle Guillerm; Emmanuel Gyan; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Primary central nervous system lymphoma in immunocompetent adults: poor results mainly associated with high treatment related toxicities.
Leukemia & lymphoma 2002;43(9):1819-22.
2002: Nicolas Boissel; Jean-Michel Cayuela; Claude Preudhomme; Xavier Thomas; Nathalie Grardel; Xavier Fund; Isabelle Tigaud; Emmanuel Raffoux; Philippe Rousselot; François Sigaux; Laurent Degos; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy.
Leukemia 2002;16(9):1699-704.
2002: Aurore Saudemont; G Buffenoir; A Denys; P Desreumaux; Nathalie Jouy; Dominique Hetuin; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.
Leukemia 2002;16(9):1637-44.
2002: Batia Stark; Marta Jeison; Claude Preudhomme; Pierre Fenaux; Shifra Ash; Yifat Korek; Jerry Stein; Rina Zaizov; Isaac Yaniv
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins.
British journal of haematology 2002;118(4):1082-6.
2002: Ibrahim Yakoub-Agha; Abir Fawaz; O Folliot; Gaëlle Guillerm; Bruno Quesnel; Pierre Fenaux; Francis Bauters; Jean-Pierre Jouet; Franck Morschhauser
Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study.
Bone marrow transplantation 2002;30(4):229-34.
2002: Catherine Roche-Lestienne; Valérie Soenen-Cornu; Nathalie Grardel-Duflos; Jean-Luc Laï; Noël Philippe; Thierry Facon; Pierre Fenaux; Claude Preudhomme
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.
Blood 2002;100(3):1014-8.
2002: Hugues Leroy; Christophe Roumier; Nathalie Grardel-Duflos; Elizabeth Macintyre; Pascale Lepelley; Pierre Fenaux; Claude Preudhomme
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Blood 2002;99(10):3848-50.
2002: Stéphanie Nguyen; Thierry Leblanc; Pierre Fenaux; Francis Witz; Didier Blaise; Arnaud Pigneux; Xavier Thomas; Françoise Rigal-Huguet; Bruno Lioure; Anne Auvrignon; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Gérard Socié; Hervé Dombret
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Blood 2002;99(10):3517-23.
2002: Pierre Fenaux; Stéphane de Botton
[Prognostic factors in myelodysplasia syndromes].
Pathologie-biologie 2002;50(4):256-60.
2002: Hervé Dombret; Pierre Fenaux; Steven L Soignet; Martin S Tallman
Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapy.
Seminars in hematology 2002;39(2 Suppl 1):8-13.
2002: Jean-Hugues Dalle; Martine Fournier; Brigitte Nelken; Françoise Mazingue; Jean-Luc Laï; Francis Bauters; Pierre Fenaux; Bruno Quesnel
p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia.
Blood 2002;99(7):2620-3.
2002: Rodolphe Vereecque; Ricardo Gonzalez; Pierre Fenaux; Bruno Quesnel
Systemic injection of GM-CSF increases survival in a murine model of acute leukemia.
Haematologica 2002;87(2):ELT13.
2002: Nathalie Grardel; Christophe Roumier; Valérie Soenen; Jean-Luc Lai; Isabelle Plantier; C Gheveart; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
Leukemia 2002;16(1):150-1.
2001: Vincent Ribrag; F Bibeau; A El Weshi; J Frayfer; C Fadel; C Cebotaru; K Laribi; Pierre Fenaux
Primary breast lymphoma: a report of 20 cases.
British journal of haematology 2001;115(2):253-6.
2001: Bruno Cassinat; Sylvie Chevret; Fabien Zassadowski; Nicole Balitrand; Isabelle Guillemot; Marie-Laurence Menot; Laurent Degos; Pierre Fenaux; Christine Chomienne
In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome.
Blood 2001;98(9):2862-4.
2001: Christian Rose; Nathalie Cambier; M Mahieu; Olivier Ernst; Pierre Fenaux
[Iron overload and myelodysplastic syndromes].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(5):422-32.
2001: Vincent Ribrag; M Ell Hajj; François Janot; Theodore Girinsky; Christian Domenge; Guy Schwaab; Pierre Fenaux; Jacques Bosq
Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.
Leukemia 2001;15(7):1123-6.
2001: Valérie Soenen; Pascale Lepelley; Emmanuel Gyan; Claude Preudhomme; Jean-Luc Lai; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype.
Leukemia 2001;15(7):1054-9.
2001: Gaëlle Guillerm; Emmanuel Gyan; Dariusz Wolowiec; Thierry Facon; Hervé Avet-Loiseau; Kazimierz Kuliczkowski; Francis Bauters; Pierre Fenaux; Bruno Quesnel
p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance.
Blood 2001;98(1):244-6.
2001: E Bourgeois; Marie Thérèse Caulier; C Rose; Brigitte Dupriez; Francis Bauters; Pierre Fenaux
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Leukemia 2001;15(6):950-3.
2001: Jean-Marie Vantelon; Jean-Nicolas Munck; Jean-Henri Bourhis; José-Luis Pico; C Fadel; Ayhan Ulusakarya; Patrice Carde; Pierre Fenaux; Vincent Ribrag
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.
Bone marrow transplantation 2001;27(5):531-6.
2001: Catherine Nisse; Jean-Marie Haguenoer; B Grandbastien; Claude Preudhomme; B Fontaine; J M Brillet; R Lejeune; Pierre Fenaux
Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
British journal of haematology 2001;112(4):927-35.
2000: Stéphane de Botton; Sylvie Chevret; M Sanz; Hervé Dombret; Xavier Thomas; Agnès Guerci; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; Pascale Cony-Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; Jesús San Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; K Geiser; Urs Hess; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Christine Chomienne; Laurent Degos; Pierre Fenaux
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
British journal of haematology 2000;111(3):801-6.
2000: Claude Preudhomme; D Warot-Loze; Christophe Roumier; Nathalie Grardel-Duflos; Richard Garand; Jean-Luc Lai; Nicole Dastugue; Elizabeth Macintyre; Claude Denis; Francis Bauters; Jean-Pierre Kerckaert; Alain Cosson; Pierre Fenaux
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Blood 2000;96(8):2862-9.
2000: S Poulain; Pascale Lepelley; Claude Preudhomme; Nathalie Cambier; J Cornillon; Eric Wattel; Alain Cosson; Pierre Fenaux
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes.
British journal of haematology 2000;110(3):591-8.
2000: Wolf-Karsten Hofmann; W Jonathan Kell; Pierre Fenaux; Sylvie Castaigne; Arnold Ganser; Christine Chomienne; R Burnett; C Kowal; Dieter Hoelzer; Alan K Burnett
Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
Leukemia 2000;14(9):1583-8.
2000: Pierre Fenaux; Sylvie Chevret; Agnès Guerci; Nathalie Fegueux; Hervé Dombret; Xavier Thomas; M Sanz; H Link; Frédéric Maloisel; Claude Gardin; Dominique Bordessoule; Anne-Marie Stoppa; Alain Sadoun; P Muus; H Wandt; P Mineur; J A Whittaker; Martin Fey; Marie-Thérèse Daniel; Sylvie Castaigne; Laurent Degos
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.
Leukemia 2000;14(8):1371-7.
2000: Rodolphe Vereecque; G Buffenoir; Claude Preudhomme; Dominique Hetuin; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.
Gene therapy 2000;7(15):1312-6.
2000: Nathalie Cambier; Valérie Soenen-Cornu; Jean-Luc Laï; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
Haematologica 2000;85(6):664-5.
2000: Xavier Thomas; Hervé Dombret; Catherine Cordonnier; Arnaud Pigneux; Claude Gardin; Agnès Guerci; Anne Vekhoff; Alain Sadoun; Aspasia Stamatoullas; Nathalie Fegueux; Frédéric Maloisel; Jean-Yves Cahn; Oumedaly Reman; Nicole Gratecos; Christian Berthou; Francoise Huguet; P Kotoucek; Philippe Travade; Agnès Buzyn; Thierry de Revel; Jean-Pierre Vilque; P Naccache; Christine Chomienne; Laurent Degos; Pierre Fenaux
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Leukemia 2000;14(6):1006-13.
2000: Claude Preudhomme; Christophe Roumier; M P Hildebrand; E Dallery-Prudhomme; Danièle Lantoine; Jean-Luc Laï; Agnès Daudignon; C Adenis; Francis Bauters; Pierre Fenaux; Jean-Pierre Kerckaert; Sylvie Galiègue-Zouitina
Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma.
Oncogene 2000;19(16):2023-32.
2000: Rodolphe Vereecque; G Buffenoir; Ricardo Gonzalez; Nathalie Cambier; Dominique Hetuin; Francis Bauters; Pierre Fenaux; Bruno Quesnel
gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells.
British journal of haematology 2000;108(4):825-31.
2000: Jean-Marie Vantelon; serge koscielny; Philippe Brault; Jean-Henri Bourhis; Vincent Ribrag; José-Luis Pico; Pierre Fenaux; Jean-Nicolas Munck
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.
Bone marrow transplantation 2000;25(5):495-9.
2000: Bruno Cassinat; Fabien Zassadowski; Nicole Balitrand; C Barbey; Jean-Didier Rain; Pierre Fenaux; Laurent Degos; Michel Vidaud; Christine Chomienne
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR.
Leukemia 2000;14(2):324-8.
2000: Franck Morschhauser; Jean-Michel Cayuela; S Martini; André Baruchel; Philippe Rousselot; Gérard Socié; P Berthou; Jean-Pierre Jouet; N Straetmans; François Sigaux; Pierre Fenaux; Claude Preudhomme
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):788-94.
2000: Nicolas Da Silva; Sandrine Meyer-Monard; Marie-Laurence Menot; Antonio Parrado; A Lebel; Nicole Balitrand; Pierre Fenaux; Jean-Michel Micléa; Philippe Rousselot; Laurent Degos; Hervé Dombret; Christine Chomienne
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(5):316-28.
2000: Christophe Roumier; Sylvie Galiègue-Zouitina; Christian Bastard; Valérie Soenen; Jean-Luc Laï; Claude Denis; Gérard Buchonnet; Jean-Pierre Kerckaert; Alain Cosson; Pierre Fenaux; Claude Preudhomme
FISH analysis with a YAC probe improves detection of LAZ3/BCL6 rearrangement in non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):117-25.
2000: Ayhan Ulusakarya; Elisabeth Chachaty; Jean-Marie Vantelon; A Youssef; C Tancrède; José-Luis Pico; Jean-Henri Bourhis; Pierre Fenaux; Jean-Nicolas Munck
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):111-6.
1999: Christophe Roumier; Agnès Daudignon; Valérie Soenen; Brigitte Dupriez; Marc Wetterwald; Jean-Luc Lai; Alain Cosson; Pierre Fenaux; Claude Preudhomme
p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Haematologica 1999;84(12):1075-80.
1999: Eric Archimbaud; O G Ottmann; J A Yin; Klaus Lechner; Hervé Dombret; MA Sanz; Gerhard Heil; Pierre Fenaux; W Brugger; A Barge; C O'Brien-Ewen; James Matcham; Dieter Hoelzer
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia.
Blood 1999;94(11):3694-701.
1999: Ricardo Gonzalez; Rodolphe Vereecque; Thomas Wickham; T Facon; Dominique Hetuin; Imre Kovesdi; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells.
Human gene therapy 1999;10(16):2709-17.
1999: Reda Bouabdallah; François Lefrère; C Rose; P Chaïbi; Jean-Luc Harousseau; J P Vernant; Sylvie Castaigne; Frédéric Bauduer; J M Zini; Diane Coso; Bruno Varet; J Robert; Pierre Fenaux
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Leukemia 1999;13(10):1491-6.
1999: S Poulain; Pascale Lepelley; Nathalie Cambier; Eric Wattel; Pierre Fenaux; Alain Cosson
[Assessment of P glycoprotein expression by immunocytochemistry and flow cytometry coupled with functional efflux analysis: application to acute myeloid leukemia].
Annales de biologie clinique 1999;57(5):595-600.
1999: Pierre Fenaux; C Chastang; Sylvie Chevret; M Sanz; Hervé Dombret; Eric Archimbaud; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; P C Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; JS Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Laurent Degos
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1999;94(4):1192-200.
1999: Xavier Thomas; Pierre Fenaux; Hervé Dombret; S Delair; François Dreyfus; Hervé Tilly; Anne Vekhoff; Pascale Cony-Makhoul; Véronique Leblond; Xavier Troussard; Catherine Cordonnier; Thierry de Revel; M Simon; Franck E Nicolini; Anne-Marie Stoppa; Maud Janvier; Dominique Bordessoule; Philippe Rousselot; Martine Ffrench; Jean-Pierre Marie; Eric Archimbaud
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
Leukemia 1999;13(8):1214-20.
1999: Ayhan Ulusakarya; Jean-Marie Vantelon; Jean-Nicolas Munck; Pierre Fenaux; K Rerat
Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia.
American journal of hematology 1999;61(2):155-6.
1999: Claude Preudhomme; Françoise Révillion; A Merlat; Louis Hornez; Christophe Roumier; N Duflos-Grardel; J P Jouet; Alain Cosson; Jean-Philippe Peyrat; Pierre Fenaux
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
Leukemia 1999;13(6):957-64.
1999: Claude Preudhomme; L Chams-Eddine; Christophe Roumier; N Duflos-Grardel; Claude Denis; Alain Cosson; Pierre Fenaux
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Leukemia 1999;13(5):818-23.
1999: Rodolphe Vereecque; G Buffenoir; R Gonzalez; C Preudhomme; Pierre Fenaux; Bruno Quesnel
A new murine aggressive leukemic model.
Leukemia research 1999;23(4):415-6.
1999: Eric Wattel; Eric Solary; Xavier Leleu; François Dreyfus; Annie Brion; Jean-Pierre Jouet; L Hoang-Ngoc; Frédéric Maloisel; Agnès Guerci; H Rochant; Nicole Gratecos; Philippe Casassus; Maud Janvier; Pauline Brice; Pascale Lepelley; Pierre Fenaux
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.
Leukemia 1999;13(4):524-9.
1999: Ricardo Gonzalez; Rodolphe Vereecque; Thomas Wickham; M Vanrumbeke; Imre Kovesdi; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein.
Gene therapy 1999;6(3):314-20.
1999: I Plantier-Colcher; Brigitte Dupriez; M Simon; L Detourmignies; Jean-Pierre Jouet; Pierre Fenaux; Francis Bauters; P Morel
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
Leukemia 1999;13(2):282-8.
1999: A Merlat; Jean-Luc Lai; Y Sterkers; Jean-Loup Demory; Francis Bauters; Claude Preudhomme; Pierre Fenaux
Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
Leukemia 1999;13(2):250-7.
1999: S Poulain; Pascale Lepelley; Nathalie Cambier; Alain Cosson; Pierre Fenaux; Eric Wattel
Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
Advances in experimental medicine and biology 1999;457():57-63.
1999: Eric Wattel; Eric Solary; B Hecquet; Denis Caillot; Norbert Ifrah; Annie Brion; Noël Milpied; Maud Janvier; Agnès Guerci; H Rochant; Catherine Cordonnier; François Dreyfus; A Veil; L Hoang-Ngoc; Anne-Marie Stoppa; Nicole Gratecos; Alain Sadoun; Hervé Tilly; Pauline Brice; Bruno Lioure; Bernard Desablens; Bernard Pignon; J P Abgrall; Michel Leporrier; Pierre Fenaux
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Advances in experimental medicine and biology 1999;457():35-46.
1998: Stéphane de Botton; Hervé Dombret; M Sanz; JS Miguel; Denis Caillot; R Zittoun; Martine Gardembas; A Stamatoulas; E Condé; Agnès Guerci; Claude Gardin; K Geiser; D C Makhoul; Oumedaly Reman; Javier de la Serna; F Lefrere; Christine Chomienne; C Chastang; Laurent Degos; Pierre Fenaux
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1998;92(8):2712-8.
1998: Eric Wattel; Eric Solary; B Hecquet; Denis Caillot; Norbert Ifrah; Annie Brion; Béatrice Mahé; Noël Milpied; Maud Janvier; Agnès Guerci; H Rochant; Catherine Cordonnier; François Dreyfus; Agnès Buzyn; L Hoang-Ngoc; Anne-Marie Stoppa; Nicole Gratecos; Alain Sadoun; A Stamatoulas; Hervé Tilly; Pauline Brice; Frédéric Maloisel; Bruno Lioure; Bernard Desablens; Pierre Fenaux
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.
British journal of haematology 1998;102(4):1015-24.
1998: Pascale Lepelley; Nathalie Grardel; O Erny; T Iaru; V Obein; Alain Cosson; Pierre Fenaux
Fas/APO-1 (CD95) expression in myelodysplastic syndromes.
Leukemia & lymphoma 1998;30(3-4):307-12.
1998: Jean-Luc Laï; Agnès Daudignon; Jean-Pierre Kerckaert; Sylvie Galiègue-Zouitina; L Detourmignies; P Morel; Francis Bauters; Pierre Fenaux
Translocation (3;13)(q27;q14): a nonrandom and probably secondary structural change in non-Hodgkin lymphomas.
Cancer genetics and cytogenetics 1998;103(2):140-3.
1998: Pascale Lepelley; S Poulain; Nathalie Grardel; Claude Preudhomme; Alain Cosson; Pierre Fenaux
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
Leukemia & lymphoma 1998;29(5-6):547-51.
1998: Bruno Quesnel; Gaëlle Guillerm; Rodolphe Vereecque; Eric Wattel; Claude Preudhomme; Francis Bauters; M Vanrumbeke; Pierre Fenaux
Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
Blood 1998;91(8):2985-90.
1998: Pierre Fenaux; S De Botton
Retinoic acid syndrome. Recognition, prevention and management.
Drug safety : an international journal of medical toxicology and drug experience 1998;18(4):273-9.
1998: T Vallespí; Michèle Imbert; C Mecucci; Claude Preudhomme; Pierre Fenaux
Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.
Haematologica 1998;83(3):258-75.
1998: A S Michallet; Jean-Luc Lai; Francis Bauters; Pierre Fenaux; Bruno Quesnel
A new case of therapy-related acute myeloid leukaemia with t(8;16)(p11;p13)
British journal of haematology 1998;100(4):801-2.
1998: Valérie Soenen; Claude Preudhomme; Christophe Roumier; Jean-Luc Laï; Pascale Lepelley; T Facon; D Pagniez; Pierre Fenaux
Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
Leukemia 1998;12(2):238-41.
1998: Valérie Soenen; Claude Preudhomme; Christophe Roumier; Agnès Daudignon; Jean-Luc Laï; Pierre Fenaux
17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
Blood 1998;91(3):1008-15.
1998: Y Sterkers; Claude Preudhomme; Jean-Luc Laï; Jean-Loup Demory; Marie Thérèse Caulier; Eric Wattel; Dominique Bordessoule; Francis Bauters; Pierre Fenaux
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Blood 1998;91(2):616-22.
1998: Claude Preudhomme; M Vanrumbeke; L Detourmignies; T Facon; Pascale Lepelley; thierry soussi; Pierre Fenaux
Very low incidence of p53 antibodies in adult non-Hodgkin's lymphoma and multiple myeloma.
British journal of haematology 1998;100(1):184-6.
1997: M Hebbar; D Kozlowski; Eric Wattel; S Mastrini; M Diévart; B Duclos; B Bonaz; H d'Almagne; J Belaiche; J F Colombel; Pierre Fenaux
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature.
Leukemia 1997;11(12):2188-91.
1997: C Preudhomme; Pierre Fenaux
The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies.
British journal of haematology 1997;98(3):502-11.
1997: Eric Wattel; Stéphane de Botton; J Luc Laï; Claude Preudhomme; Pascale Lepelley; Francis Bauters; Pierre Fenaux
Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders.
British journal of haematology 1997;98(4):983-91.
1997: Claude Preudhomme; Catherine Nisse; M Hebbar; M Vanrumbeke; A Brizard; Jean-Luc Lai; Pierre Fenaux
Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.
Leukemia 1997;11(9):1580-2.
1997: Nathalie Cambier; André Baruchel; Marie-Hélène Schlageter; Marie-Laurence Menot; Eric Wattel; Pierre Fenaux; Christine Chomienne
Chronic myelomonocytic leukemia: from biology to therapy.
Hematology and cell therapy 1997;39(2):41-8.
1997: Pierre Fenaux; Christine Chomienne; Laurent Degos
Acute promyelocytic leukemia: biology and treatment.
Seminars in oncology 1997;24(1):92-102.
1997: Claude Preudhomme; N Henic; B Cazin; Jean-Luc Lai; M F Bertheas; M Vanrumbeke; F Lemoine; J P Jouet; E Deconninck; B Nelken; Alain Cosson; Pierre Fenaux
Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL).
Leukemia 1997;11(2):294-8.
1996: Pascale Lepelley; L Campergue; Nathalie Grardel; Claude Preudhomme; Alain Cosson; Pierre Fenaux
Is apoptosis a massive process in myelodysplastic syndromes?
British journal of haematology 1996;95(2):368-71.
1996: Bruno Quesnel; Claude Preudhomme; Pascale Lepelley; D Hetuin; M Vanrumbeke; Francis Bauters; T Velu; Pierre Fenaux
Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation.
British journal of haematology 1996;95(2):291-8.
1996: Pierre Fenaux
Myelodysplastic syndromes.
Hematology and cell therapy 1996;38(5):363-80.
1996: Eric Wattel; Agnès Guerci; B Hecquet; T Economopoulos; A Copplestone; B Mahé; M E Couteaux; L Resegotti; V Voglova; Charles Foussard; B Pegourié; J L Michaux; Eric DECONINCK; A M Stoppa; G Mufti; David Oscier; Pierre Fenaux
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
Blood 1996;88(7):2480-7.
1996: Christine Chomienne; Pierre Fenaux; Laurent Degos
Retinoid differentiation therapy in promyelocytic leukemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(9):1025-30.
1996: Mohamed Hebbar; Cécile Kaplan; Marie Thérèse Caulier; Eric Wattel; P Morel; M Wetterwald; Francis Bauters; Pierre Fenaux
Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
British journal of haematology 1996;94(1):112-5.
1996: Nathalie Cambier; Eric Wattel; Marie-Laurence Menot; A Guerci; Christine Chomienne; Pierre Fenaux
All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study.
Leukemia 1996;10(7):1164-7.
1996: Eric Archimbaud; V Leblond; Pierre Fenaux; Hervé Dombret; Catherine Cordonnier; François Dreyfus; Pascale Cony-Makhoul; Hervé Tilly; X Troussard; G Auzanneau; Xavier Thomas; Martine Ffrench; J P Marie
Timed sequential chemotherapy for advanced acute myeloid leukemia.
Hematology and cell therapy 1996;38(2):161-7.
1996: Pierre Fenaux; L Degos
Treatment of acute promyelocytic leukaemia.
Baillière's clinical haematology 1996;9(1):107-28.
1996: Claude Preudhomme; N Philippe; E Macintyre; N Henic; Jean-Luc Lai; Jean-Pierre Jouet; Alain Cosson; Pierre Fenaux
Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus?
Leukemia 1996;10(1):186-8.
1996: N Henic; Claude Preudhomme; M Noel; J Lai; Marc Wetterwald; M Simon; Pierre Fenaux
Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha.
Leukemia 1996;10(1):185-6.
1996: Eric Wattel; M Vanrumbeke; Mohamed Amine Abina; Nathalie Cambier; Claude Preudhomme; Hedi Haddada; Pierre Fenaux
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.
Leukemia 1996;10(1):171-4.
1995: Eric Wattel; Pascale Lepelley; A Merlat; C Sartiaux; Francis Bauters; J P Jouet; Pierre Fenaux
Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.
Leukemia 1995;9(11):1870-4.
1995: A Agadir; M Cornic; P Lefebvre; Bernard Gourmel; M Jérôme; Laurent Degos; Pierre Fenaux; Christine Chomienne
All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2517-23.
1995: Marie Thérèse Caulier; F Darloy; C Rose; G Camier; P Morel; Francis Bauters; Pierre Fenaux
Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy.
British journal of haematology 1995;91(1):208-11.
1995: Marc Zandecki; T Facon; Claude Preudhomme; M Vanrumbeke; A Vachee; Bruno Quesnel; Jean-Luc Lai; Alain Cosson; Pierre Fenaux
The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Leukemia & lymphoma 1995;18(5-6):497-503.
1995: F Morschhauser; Eric Wattel; D Pagniez; V Lovi; C Rose; Francis Bauters; Pierre Fenaux
Glomerular injury in chronic myelomonocytic leukemia.
Leukemia & lymphoma 1995;18(5-6):479-83.
1995: N Henic; Pierre Fenaux; Jean-Luc Lai; Claude Preudhomme
RNA for reverse PCR analysis can be obtained from bone marrow cells prepared for cytogenetic analysis and stored at -20 degrees C for several years.
Leukemia 1995;9(8):1409-11.
1995: Claude Preudhomme; E Wattel; Jean-Luc Lai; N Henic; L Meyer; M P Noel; Alain Cosson; Jean-Pierre Jouet; Pierre Fenaux
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases.
Leukemia & lymphoma 1995;18(3-4):265-71.
1995: Valérie Soenen; Pierre Fenaux; M Flactif; Pascale Lepelley; Jean-Luc Lai; Alain Cosson; Claude Preudhomme
Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
British journal of haematology 1995;90(3):701-6.
1995: Hervé Dombret; C Chastang; Pierre Fenaux; J Reiffers; Dominique Bordessoule; Reda Bouabdallah; F Mandelli; A Ferrant; G Auzanneau; Hervé Tilly
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
The New England journal of medicine 1995;332(25):1678-83.
1995: Laurent Degos; Hervé Dombret; Christine Chomienne; Marie-Thérèse Daniel; J M Micléa; C Chastang; Sylvie Castaigne; Pierre Fenaux
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
Blood 1995;85(10):2643-53.
1995: Mohamed Hebbar; M Brouillard; Eric Wattel; M Decoulx; Pierre-Yves Hatron; Bernard Devulder; Pierre Fenaux
Association of myelodysplastic syndrome and relapsing polychondritis: further evidence.
Leukemia 1995;9(4):731-3.
1995: Pascale Lepelley; Valérie Soenen; Claude Preudhomme; A Merlat; Alain Cosson; Pierre Fenaux
bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.
Leukemia 1995;9(4):726-30.
1995: Jean-Luc Lai; Claude Preudhomme; Marc Zandecki; M Flactif; M Vanrumbeke; Pascale Lepelley; Eric Wattel; Pierre Fenaux
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Leukemia 1995;9(3):370-81.
1995: Pierre Fenaux; C Chastang; Christine Chomienne; Sylvie Castaigne; M Sanz; H Link; B Löwenberg; M Fey; E Archim-Baud; Laurent Degos
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
Leukemia & lymphoma 1995;16(5-6):431-7.
1995: Eric Archimbaud; Xavier Thomas; V Leblond; Mauricette Michallet; Pierre Fenaux; Catherine Cordonnier; François Dreyfus; X Troussard; Jérôme Jaubert; Philippe Travade
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):11-8.
1995: Hervé Dombret; M L Scrobohaci; Marie-Thérèse Daniel; J M Micléa; Sylvie Castaigne; Christine Chomienne; Pierre Fenaux; Laurent Degos
In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Leukemia 1995;9(1):19-24.
1994: I Plantier; Jean-Luc Lai; Eric Wattel; Francis Bauters; Pierre Fenaux
Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up.
Leukemia research 1994;18(12):885-8.
1994: M Flactif; Jean-Luc Laï; Pierre Fenaux
Reassessment of an apparent t(12;17)(p11;p11) as an unbalanced t(17;21)(p11;q11) in a case of B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;78(1):108-11.
1994: N Henic; Claude Preudhomme; M Vanrumbeke; Pierre Fenaux
Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemia.
Leukemia 1994;8(10):1795-6.
1994: Bruno Quesnel; Claude Preudhomme; D Oscier; Pascale Lepelley; M Collyn-d'Hooghe; T Facon; Marc Zandecki; Pierre Fenaux
Over-expression of the MDM2 gene is found in some cases of haematological malignancies.
British journal of haematology 1994;88(2):415-8.
1994: C Dubois; Marie-Hélène Schlageter; A de Gentile; Nicole Balitrand; Marie-Elisabeth Toubert; I Krawice; Pierre Fenaux; Sylvie Castaigne; Y Najean; Laurent Degos
Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Leukemia 1994;8(10):1750-7.
1994: C Rose; Eric Wattel; Y Bastion; E Berger; Francis Bauters; Bertrand Coiffier; Pierre Fenaux
Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases.
Leukemia 1994;8(9):1458-62.
1994: Pascale Lepelley; Claude Preudhomme; M Vanrumbeke; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Leukemia 1994;8(8):1342-9.
1994: Pierre Fenaux; E Wattel; Eric Archimbaud; M Sanz; B Hecquet; N Fegueux; A Guerci; H Link; M Fey; Sylvie Castaigne
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group.
Blood 1994;84(2):666-7.
1994: Eric Archimbaud; V Leblond; Pierre Fenaux; Hervé Dombret; Catherine Cordonnier; P Cony-Makoul; François Dreyfus; X Troussard; G Auzanneau; A M Stoppa
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].
Nouvelle revue française d'hématologie 1994;36 Suppl 2():S145-8.
1994: Sylvie Castaigne; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; M Simon; Brigitte Dupriez; G Auzanneau; Michel Legros; G Tertian
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].
Nouvelle revue française d'hématologie 1994;36 Suppl 2():S139-40.
1994: M Flactif; Jean-Luc Lai; Claude Preudhomme; Pierre Fenaux
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Leukemia 1994;8(6):1012-8.
1994: C Dubois; Marie-Hélène Schlageter; A de Gentile; Fabien Guidez; Nicole Balitrand; Marie-Elisabeth Toubert; I Krawice; Pierre Fenaux; Sylvie Castaigne; Y Najean
Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
Blood 1994;83(11):3264-70.
1994: Pascale Lepelley; Valérie Soenen; Claude Preudhomme; Jean-Luc Lai; Alain Cosson; Pierre Fenaux
Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.
Leukemia 1994;8(6):998-1004.
1994: Bruno Quesnel; Claude Preudhomme; M Vanrumbeke; A Vachee; Jean-Luc Lai; Pierre Fenaux
Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
Leukemia 1994;8(5):878-80.
1994: Claude Preudhomme; A Vachee; F Morschauser; N Henic; Alain Cosson; Pierre Fenaux
Immunoglobulin and T-cell receptor delta gene rearrangements are rarely found in myelodysplastic syndromes in chronic phase.
Leukemia research 1994;18(5):365-71.
1994: Eric Wattel; Nathalie Cambier; Marie Thérèse Caulier; D Sautière; Francis Bauters; Pierre Fenaux
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
British journal of haematology 1994;87(1):205-8.
1994: Claude Preudhomme; A Vachee; Pascale Lepelley; M Vanrumbeke; Marc Zandecki; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes.
British journal of haematology 1994;87(1):61-7.
1994: Thierry Facon; Marie Thérèse Caulier; Eric Wattel; Jean-Pierre Jouet; Francis Bauters; Pierre Fenaux
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients.
British journal of haematology 1994;86(3):678-80.
1994: Pierre Fenaux
Treatment of newly diagnosed APL. The best choice is not ATRA or chemotherapy ... but a combination of both. European APL Group.
Leukemia 1994;8 Suppl 2():S59-61; discussion S62.
1994: Pierre Fenaux; C Chastang; L Degos
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.
Leukemia 1994;8 Suppl 2():S42-7.
1994: Pierre Fenaux
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
Leukemia 1994;8 Suppl 3():S70-2.
1993: Eric Wattel; Jean-Luc Laï; Mohamed Hebbar; Claude Preudhomme; D Grahek; P Morel; Francis Bauters; Pierre Fenaux
De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?
Leukemia research 1993;17(11):921-6.
1993: Claude Preudhomme; Pascale Lepelley; A Vachee; Valérie Soenen; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Leukemia 1993;7(11):1888-90.
1993: L Delva; M Cornic; Nicole Balitrand; Fabien Guidez; J M Micléa; Alain Delmer; F Teillet; Pierre Fenaux; Sylvie Castaigne; Laurent Degos
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
Blood 1993;82(7):2175-81.
1993: P Morel; Mohamed Hebbar; Jean-Luc Lai; A Duhamel; Claude Preudhomme; Eric Wattel; Francis Bauters; Pierre Fenaux
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Leukemia 1993;7(9):1315-23.
1993: Eric Wattel; B Hecquet; D Grahek; Mohamed Hebbar; P Morel; Jean-Luc Lai; Francis Bauters; Pierre Fenaux
Long-term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors.
Leukemia research 1993;17(9):733-9.
1993: Claude Preudhomme; Bruno Quesnel; A Vachee; Pascale Lepelley; M Collyn-D'Hooghe; Eric Wattel; Pierre Fenaux
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.
Leukemia 1993;7(8):1291-3.
1993: T Facon; M Brouillard; A Duhamel; P Morel; M Simon; J P Jouet; F Bauters; Pierre Fenaux
Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1553-8.
1993: Claude Preudhomme; A Vachee; Bruno Quesnel; Eric Wattel; Alain Cosson; Pierre Fenaux
Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Leukemia 1993;7(7):1071.
1993: Claude Preudhomme; Pierre Fenaux; J L Lal; Pascale Lepelley; C Sartiaux; M Collyn-d'Hooghe; Marc Zandecki; Alain Cosson; J P Jouet; Jean-Pierre Kerckaert
Philadelphia negative, BCR-ABL positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis.
Leukemia 1993;7(7):1054-7.
1993: Pierre Fenaux
[Myelodysplastic syndromes or refractory anemias].
La Revue du praticien 1993;43(11):1379-85.
1993: L Detourmignies; Eric Wattel; Jean-Luc Laï; Francis Bauters; Pierre Fenaux
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.
Annals of hematology 1993;66(5):235-40.
1993: Eric Archimbaud; Pierre Fenaux; J Reiffers; Catherine Cordonnier; V Leblond; Philippe Travade; X Troussard; Hervé Tilly; G Auzanneau; J P Marie
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
Leukemia 1993;7(3):372-7.
1993: Pascale Lepelley; Claude Preudhomme; C Sartiaux; C Ghevaert; Jean-Luc Lai; T Iaru; Pierre Fenaux; Alain Cosson
Immunological detection of myeloperoxidase in poorly differentiated acute leukemia.
European journal of haematology 1993;50(3):155-9.
1993: Thierry Facon; J P Jouet; J L Lai; Pierre Fenaux; J J Huart; J C Monnier; D Pagniez; Francis Bauters
Early paternity and relapse after bone marrow transplantation.
American journal of hematology 1993;42(2):231-2.
1993: Pierre Fenaux
Management of acute promyelocytic leukemia.
European journal of haematology 1993;50(2):65-73.
1993: Pierre Fenaux
The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Acta haematologica 1993;89 Suppl 1():22-7.
1993: P Morel; Brigitte Dupriez; B Gosselin; Pierre Fenaux; M H Estienne; Thierry Facon; Jean-Pierre Jouet; Francis Bauters
Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases.
Cancer 1993;71(1):207-15.
1992: Claude Preudhomme; Jean-Luc Lai; I Plantier; Jean-Loup Demory; Marc Zandecki; Pierre Fenaux
Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
British journal of haematology 1992;82(3):623-6.
1992: Thierry Facon; Marie Thérèse Caulier; Pierre Fenaux; I Plantier; X Marchandise; M Ribet; Jean-Pierre Jouet; Francis Bauters
Accessory spleen in recurrent chronic immune thrombocytopenic purpura.
American journal of hematology 1992;41(3):184-9.
1992: Pierre Fenaux; Claude Preudhomme; Mohamed Hebbar
The role of intensive chemotherapy in myelodysplastic syndromes.
Leukemia & lymphoma 1992;8(1-2):43-9.
1992: E Auxenfants; P Morel; Jean-Luc Lai; C Sartiaux; L Detourmignies; Francis Bauters; Pierre Fenaux
Secondary acute lymphoblastic leukemia with t (4;11): report on two cases and review of the literature.
Annals of hematology 1992;65(3):143-6.
1992: P Morel; Eric Lepage; P Brice; Brigitte Dupriez; M F D'Agay; Pierre Fenaux; B Gosselin; F Bauters; Christian Gisselbrecht
Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1078-85.
1992: Pierre Fenaux; Claude Preudhomme; Jean-Luc Laï; I Quiquandon; P Jonveaux; M Vanrumbeke; C Sartiaux; P Morel; M H Loucheux-Lefebvre; Francis Bauters
Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.
Leukemia 1992;6(4):246-50.
1992: Pierre Fenaux; Claude Preudhomme; I Quiquandon; P Jonveaux; Jean-Luc Laï; M Vanrumbeke; M H Loucheux-Lefebvre; Francis Bauters; Roland Berger; Jean-Pierre Kerckaert
Mutations of the P53 gene in acute myeloid leukaemia.
British journal of haematology 1992;80(2):178-83.
1992: Pierre Fenaux; P Jonveaux; I Quiquandon; Claude Preudhomme; Jean-Luc Lai; M Vanrumbeke; M H Loucheux-Lefebvre; Francis Bauters; Roland Berger; Jean-Pierre Kerckaert
Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.
Leukemia 1992;6(1):42-6.
1991: P Jonveaux; Pierre Fenaux; I Quiquandon; J M Pignon; Jean-Luc Laï; M H Loucheux-Lefebvre; Michel Goossens; Francis Bauters; Roland Berger
Mutations in the p53 gene in myelodysplastic syndromes.
Oncogene 1991;6(12):2243-7.
1991: Guillaume Dighiero; Philippe Travade; S Chevret; Pierre Fenaux; C Chastang; Jacques-Louis Binet
B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL.
Blood 1991;78(8):1901-14.
1991: Pierre Fenaux; P Jonveaux; I Quiquandon; Jean-Luc Laï; J M Pignon; M H Loucheux-Lefebvre; Francis Bauters; Roland Berger; Jean-Pierre Kerckaert
P53 gene mutations in acute myeloid leukemia with 17p monosomy.
Blood 1991;78(7):1652-7.
1991: Pierre Fenaux; G Tertian; Sylvie Castaigne; Hervé Tilly; G Leverger; H Guy; Dominique Bordessoule; R Leblay; E Le Gall; Philippe Colombat
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1556-61.
1991: Thierry Facon; M P Walter; Pierre Fenaux; P Morel; Brigitte Dupriez; C Gardin; Jean-Pierre Jouet; Francis Bauters
Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: a report on 33 patients.
Annals of hematology 1991;63(2):89-93.
1991: Thierry Facon; Marc Zandecki; Marie Thérèse Caulier; Lucienne Mannessier; Pierre Fenaux; Jean-Pierre Jouet; Francis Bauters
Usefulness of electron microscopy in the diagnosis of congenital dyserythropoietic anemia type I: report of a case.
American journal of hematology 1991;37(4):277-9.
1991: Thierry Facon; Marie Thérèse Caulier; Pierre Fenaux; Bénédicte Wibaut; A Cappelaere; I Quiquandon; Francis Bauters
Interferon alpha-2b therapy in refractory adult chronic thrombocytopenic purpura.
British journal of haematology 1991;78(3):464-5.
1991: Brigitte Dupriez; P Morel; Pierre Fenaux; I Colcher-Plantier; Thierry Facon; Francis Bauters
VIM3-ARA C: an effective salvage regimen in refractory or recurrent aggressive non Hodgkin's lymphoma. A report on 18 cases.
Hematological oncology 1991;9(4-5):259-66.
1991: Thierry Facon; Jean-Pierre Jouet; Pierre Fenaux; M P Walter; J L Lai; J L Jabinet; J P Chambon; Francis Bauters
Isolated pericardial and mediastinal relapse following allogeneic bone marrow transplantation for acute lymphoblastic leukemia.
Transplantation 1991;51(5):1125-6.
1991: Eric Archimbaud; V Leblond; Mauricette Michallet; Catherine Cordonnier; Pierre Fenaux; Philippe Travade; François Dreyfus; Jérôme Jaubert; Y Devaux; Denis Fiere
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.
Blood 1991;77(9):1894-900.
1991: Pierre Fenaux; P Morel; C Rose; Jean-Luc Lai; Jean-Pierre Jouet; Francis Bauters
Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
British journal of haematology 1991;77(4):497-501.
1991: Jean-Pierre Jouet; A Draoui; Thierry Facon; M P Noel-Walter; P Wattre; Pierre Fenaux; Brigitte Dupriez; P Morel; Francis Bauters
Should all CMV infections after bone marrow transplantation be treated?
Bone marrow transplantation 1991;7 Suppl 2():47.
1990: Christine Chomienne; P Ballerini; Nicole Balitrand; M E Huang; I Krawice; Sylvie Castaigne; Pierre Fenaux; P Tiollais; A Dejean; Laurent Degos
The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.
Leukemia 1990;4(12):802-7.
1990: Christine Chomienne; P Ballerini; Nicole Balitrand; Marie-Thérèse Daniel; Pierre Fenaux; Sylvie Castaigne; Laurent Degos
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.
Blood 1990;76(9):1710-7.
1990: Thierry Facon; Lucienne Mannessier; Pascale Lepelley; J Weill; Pierre Fenaux; Brigitte Dupriez; P Morel; Jean-Pierre Jouet
Congenital diserythropoietic anemia type I. Report on monozygotic twins with associated hemochromatosis and short stature.
Blut 1990;61(4):248-50.
1990: Pierre Fenaux; M Simon; Marie Thérèse Caulier; J L Lai; Jenny Goudemand; Francis Bauters
Clinical course of essential thrombocythemia in 147 cases.
Cancer 1990;66(3):549-56.
1990: Jean-Luc Laï; Marc Zandecki; Pierre Fenaux; F Le Baron; Francis Bauters; Alain Cosson; M Deminatti
Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
Cancer genetics and cytogenetics 1990;46(2):173-83.
1990: Pierre Fenaux; C Vanhaesbroucke; M H Estienne; C Preud'homme; D Pagniez; Thierry Facon; F Millot; Francis Bauters
Acute monocytic leukaemia in adults: treatment and prognosis in 99 cases.
British journal of haematology 1990;75(1):41-8.
1990: Thierry Facon; J Goudemand; C Caron; Marc Zandecki; M H Estienne; Pierre Fenaux; Alain Cosson
Simultaneous occurrence of grey platelet syndrome and idiopathic pulmonary fibrosis: a role for abnormal megakaryocytes in the pathogenesis of pulmonary fibrosis?
British journal of haematology 1990;74(4):542-3.
1990: Pierre Fenaux; I Quiquandon; Marie Thérèse Caulier; M Simon; M P Walter; Francis Bauters
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases.
Blut 1990;60(4):238-41.
1990: I Quiquandon; Pierre Fenaux; Marie Thérèse Caulier; D Pagniez; J J Huart; Francis Bauters
Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases.
British journal of haematology 1990;74(2):223-8.
1990: Pierre Fenaux; I Quiquandon; J J Huart; Marie Thérèse Caulier; Francis Bauters
The role of danazol in the treatment of refractory idiopathic thrombocytopenic purpura. A report of 22 cases.
Nouvelle revue française d'hématologie 1990;32(2):143-6.
1990: M H Estienne; Pierre Fenaux; Claude Preudhomme; Jean-Luc Lai; Marc Zandecki; Pascale Lepelley; Alain Cosson
Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
Clinical and laboratory haematology 1990;12(1):57-65.
1990: M H Delfau; Jean-Pierre Kerckaert; M Collyn d'Hooghe; Pierre Fenaux; Jean-Luc Laï; J P Jouet; B Grandchamp
Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.
Leukemia 1990;4(1):1-5.
1990: Pierre Fenaux; C Preudhomme; M Hélène Estienne; P Morel; J L Laï; Claude Gardin; J P Jouet; F Bauters
de novo myelodysplastic syndromes in adults aged 50 or less. A report on 37 cases.
Leukemia research 1990;14(11-12):1053-9.
1990: M Collyn d'Hooghe; Pierre Fenaux; Danièle Lantoine; M Loucheux-Lefebvre; Jean-Pierre Kerckaert
Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.
Nouvelle revue française d'hématologie 1990;32(3):175-7.
1990: Pierre Fenaux; M Collyn d'Hooghe; P Jonveaux; Jean-Luc Lai; Francis Bauters; M H Loucheux; Jean-Pierre Kerckaert
Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia.
Nouvelle revue française d'hématologie 1990;32(5):341-4.
1990: Sylvie Castaigne; Sylvie Chevret; Eric Lepage; françois guilhot; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; G Auzanneau; G Tertian; H Guy
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).
Nouvelle revue française d'hématologie 1990;32(5):297-300.
1990: Jean-Pierre Kerckaert; Martine Duterque-Coquillaud; M Collyn-d'Hooghe; P Morel; Marie-Ange Majérus; Jean-Luc Laï; Pierre Fenaux; Francis Bauters; Brigitte Debuire; M H Loucheux-Lefebvre
Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
Leukemia 1990;4(1):16-9.
1989: Jean-Luc Lai; M Deminatti; M H Estienne; Marc Zandecki; Brigitte Nelken; Pierre Fenaux
A new case of dic(9;12)(p13;p11) in acute lymphocytic leukemia.
Cancer genetics and cytogenetics 1989;42(2):307-8.
1989: M Collyn-d'Hooghe; Pierre Fenaux; Jean-Luc Lai; Francis Bauters; M H Loucheux-Lefebvre; Jean-Pierre Kerckaert
Absence of rearrangement of proto-oncogene MET in 88 cases of myelodysplastic syndromes (MDS).
British journal of haematology 1989;73(1):40-2.
1989: Brigitte Dupriez; Jean-Loup Demory; Jean-Luc Lai; Pierre Fenaux; Francis Bauters
Prognostic classification of myelofibrosis with myeloid metaplasia.
British journal of haematology 1989;73(1):136-7.
1989: Pierre Fenaux; M H Estienne; Jean-Luc Laï; R Beuscart; Brigitte Dupriez; Jean-Pierre Jouet; Francis Bauters
[Acquired idiopathic sideroblastic anemia. Apropos of 39 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1989;10(4):323-9.
1989: Pierre Fenaux; D Lucidarme; J L Laï; Francis Bauters
Favorable cytogenetic abnormalities in secondary leukemia.
Cancer 1989;63(12):2505-8.
1989: Jean-Luc Laï; M H Estienne; Pierre Fenaux; Pascale Lepelley; J J Huart; Francis Bauters; M Deminatti
Translocation t(10;17)(p13;q12) in two cases of acute nonlymphocytic leukemia with phagocytic activity of blasts. A new cytogenetic entity?
Cancer genetics and cytogenetics 1989;39(1):45-53.
1989: Pierre Fenaux; Jean-Luc Lai; O Miaux; Marc Zandecki; Jean-Pierre Jouet; Francis Bauters
Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases.
British journal of haematology 1989;71(3):371-6.
1989: Pierre Fenaux; Marie Thérèse Caulier; M C Hirschauer; R Beuscart; Jenny Goudemand; Francis Bauters
Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases.
European journal of haematology 1989;42(3):259-64.
1989: Jean-Luc Laï; Pierre Fenaux; M H Estienne; J J Huart; J B Savary; Pascale Lepelley; Jean-Pierre Jouet; Brigitte Nelken; Francis Bauters; M Deminatti
Translocation t(1;19)(q23;p13) in acute lymphoblastic leukemia. A report on six new cases and an unusual t(17;19)(q11;q13), with special reference to prognostic factors.
Cancer genetics and cytogenetics 1989;37(1):9-17.
1989: Jean-Luc Lai; Pierre Fenaux; Marc Zandecki; Brigitte Nelken; J J Huart; M Deminatti
Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities.
Annales de génétique 1989;32(1):26-32.
1989: Pierre Fenaux; L Lemaitre; F Ajana; I Colcher-Plantier; J P Jouet; Francis Bauters
Hepatosplenic candidiasis: an overlooked cause of prolonged fever during recovery from an episode of neutropenia.
Nouvelle revue française d'hématologie 1989;31(1):45-9.
1989: Marc Zandecki; Brigitte Dupriez; Pierre Fenaux; Brigitte Jude; A Watel; Michel Dracon; Jean-Loup Demory; Alain Cosson
Cytological and ultrastructural assessment of free crystals or precipitates associated with pseudoleukocytosis and pseudothrombocytosis in cryoglobulinemia.
Nouvelle revue française d'hématologie 1989;31(6):397-402.
1988: Pierre Fenaux; Jean-Luc Lai; Jean-Pierre Jouet; J P Pollet; Francis Bauters
Aggressive chemotherapy in adult primary myelodysplastic syndromes. A report on 29 cases.
Blut 1988;57(5):297-302.
1988: Jean-Loup Demory; Brigitte Dupriez; Pierre Fenaux; Jean-Luc Laï; R Beuscart; Jean-Pierre Jouet; M Deminatti; Francis Bauters
Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases.
Blood 1988;72(3):855-9.
1988: Pierre Fenaux; R Beuscart; Jean-Luc Lai; Jean-Pierre Jouet; F Bauters
Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1417-24.
1988: Jean-Luc Laï; Pierre Fenaux; J P Pollet; M H Estienne; J B Savary; J J Huart; M Deminatti
Acute lymphocytic leukemia with 9p anomalies. A report of four additional cases and review of the literature.
Cancer genetics and cytogenetics 1988;33(1):99-109.
1988: Pierre Fenaux; M H Estienne; Pascale Lepelley; Marc Zandecki; Jean-Luc Lai; R Beuscart; Jean-Pierre Jouet; Alain Cosson; Francis Bauters
Refractory anaemia according to the FAB classification: a report on 69 cases.
European journal of haematology 1988;40(4):318-25.
1988: Jean-Pierre Jouet; B Buchet-Bouverne; Pierre Fenaux; J P Pollet; M Simon; M P Walter; J L Leroy; Francis Puech; M Delecour; Francis Bauters
[Influence of pregnancy on the development of Hodgkin's disease].
Presse médicale (Paris, France : 1983) 1988;17(9):423-7.
1988: Pierre Fenaux; Jean-Pierre Jouet; C Delerive; M Simon; J P Pollet; P Savinel; M C Fabri; I Ciesla; B Gosselin; Francis Bauters
[Hodgkin's disease disclosed by myelofibrosis of primary appearance. Apropos of 2 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1988;9(2):149-52.
1988: Francis Bauters; Jean-Pierre Jouet; M Simon; J P Pollet; Pierre Fenaux; M P Walter
[Efficacy of pipobroman in the treatment of essential thrombocythemia].
Presse médicale (Paris, France : 1983) 1988;17(2):81.
1987: Jean-Luc Laï; Pierre Fenaux; Marc Zandecki; J B Savary; M H Estienne; Jean-Pierre Jouet; Francis Bauters; M Deminatti
Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17).
Cancer genetics and cytogenetics 1987;29(2):311-4.
1987: M Simon; Jean-Pierre Jouet; Pierre Fenaux; J P Pollet; M P Walter; Francis Bauters
The treatment of adult idiopathic thrombocytopenic purpura. Infusion of vinblastine in ITP.
European journal of haematology 1987;39(3):193-6.
1987: Pierre Fenaux; Jean-Pierre Jouet; Francis Bauters
[T-cell leukemia and lymphoma].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1987;8(4):407-14.
1987: Pascale Lepelley; Marc Zandecki; S Paquet; B Lerche; M H Estienne; Pierre Fenaux; G Torpier; Alain Cosson
Total peroxidase deficiency in eosinophils: a report on twin sisters, one with a refractory anaemia.
European journal of haematology 1987;39(1):77-81.
1987: Jean-Luc Laï; Jean-Pierre Jouet; Marc Zandecki; J B Savary; Pierre Fenaux; Pascale Lepelley; Brigitte Nelken; Francis Bauters; M Deminatti
[(9;11) (p21;q23) translocation: apropos of 2 new cases seen in acute undifferentiated monoblastic AML5a leukemia].
Nouvelle revue française d'hématologie 1987;29(5):303-6.
1987: Pierre Fenaux; Jean-Pierre Jouet; M Zandecki; Jean-Luc Lai; M Simon; J P Pollet; Francis Bauters
Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors.
British journal of haematology 1987;65(1):101-6.
1987: Pierre Fenaux; J J Huart; Lucienne Mannessier; Marie Thérèse Caulier; Marc Zandecki; Jean-Pierre Jouet; Francis Bauters
[Ineffective erythropoiesis of immunologic origin with free bilirubin jaundice in an elderly subject].
Nouvelle revue française d'hématologie 1987;29(6):383-6.
1987: Marc Zandecki; Brigitte Dupriez; Jean-Luc Laï; Pierre Fenaux; Thierry Facon; Pascale Lepelley; M H Estienne; J J Huart; Jean-Pierre Jouet
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
Nouvelle revue française d'hématologie 1987;29(6):365-9.
1987: Christine Chomienne; Y Najean; Laurent Degos; G Thomas; E Baumelou; F Calvo; Philippe Casassus; F Ciccone; Pierre Fenaux; J C Gris
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
Acta haematologica 1987;78 Suppl 1():109-15.
1987: M H Estienne; Pascale Lepelley; Marc Zandecki; Pierre Fenaux; Jean-Pierre Jouet; P Ducoulombier; F Le Baron; B Caron; O Chassaing; Alain Cosson
[Cytological diagnosis of myelodysplastic syndromes. Apropos of 200 cases].
Annales de biologie clinique 1987;45(4):402-8.
1986: M P Walter; Jean-Pierre Jouet; M Simon; J P Pollet; Pierre Fenaux; Francis Bauters
[Dosage and efficacy of antilymphocyte serum in severe bone marrow aplasia].
Presse médicale (Paris, France : 1983) 1986;15(18):846.
1986: Pierre Fenaux; Jean-Pierre Jouet; M Zandecki; M Simon; J P Pollet; M P Walter; Francis Bauters
[Hemophagocytic syndrome associated with herpes simplex virus. Apropos of a case with a fatal outcome].
Nouvelle revue française d'hématologie 1986;28(5):303-7.